data_5aiy_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5aiy _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.489 -1.444 . . . . 0.28999999999999998 109.489 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.41 HG22 ' N ' ' A' ' 3' ' ' VAL . 10.5 tt -130.31 -42.64 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.256 -1.143 . . . . 0.050000000000000003 109.29 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.434 ' CG1' ' HG3' ' B' ' 4' ' ' GLN . 2.8 t -65.77 -62.01 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.314 -0.866 . . . . 0.01 109.249 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.78 -18.01 28.29 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.397 -0.814 . . . . 0.46000000000000002 110.24 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -86.76 -35.15 19.35 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.942 -1.099 . . . . 0.23999999999999999 110.537 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.7 m -103.91 -23.77 13.33 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.976 -1.078 . . . . 0.0 111.015 -178.492 -54.903 -42.76 -97.206 104.568 2.023 104.076 129.264 -72.529 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.0 t -76.29 -2.39 31.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.204 -0.935 . . . . 0.070000000000000007 110.264 179.338 -174.583 82.104 131.925 104.871 2.022 103.039 -172.64 173.661 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.7 p -86.15 -50.33 7.08 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.473 -1.392 . . . . 0.25 109.305 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 m -155.24 36.99 0.39 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.275 -0.891 . . . . 0.28999999999999998 109.777 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.6 mp 64.22 138.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 122.003 0.906 . . . . 0.10000000000000001 110.701 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 66.7 m -95.05 174.41 7.09 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.031 -0.729 . . . . 0.050000000000000003 109.031 179.466 -72.529 129.264 -97.206 104.076 2.023 104.568 -42.76 -54.903 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.1 m -83.61 164.27 19.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.895 . . . . 0.27000000000000002 109.285 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.1 tt -58.35 -41.67 85.21 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.329 -0.857 . . . . 0.29999999999999999 110.403 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -68.44 -38.99 81.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.026 -1.046 . . . . 0.52000000000000002 110.186 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -58.38 -33.1 69.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.165 -0.959 . . . . 0.23000000000000001 109.666 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 85.1 mt -72.03 -29.53 64.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.228 -0.92 . . . . 0.01 109.487 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -62.76 -31.11 72.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.863 . . . . 0.26000000000000001 109.922 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 -58.74 -28.34 65.79 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.088 -1.007 . . . . 0.41999999999999998 109.454 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -96.92 13.18 29.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.11 110.402 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.0 t -83.06 157.04 23.03 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.836 -1.165 . . . . 0.050000000000000003 109.593 -179.497 -157.737 76.709 173.549 104.235 2.019 103.93 -89.424 -76.609 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 C--N 1.302 -1.494 0 CA-C-O 117.915 -1.041 . . . . 0.40999999999999998 109.554 -179.861 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.422 ' O ' ' CG2' ' B' ' 2' ' ' VAL . 20.8 t80 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.391 -0.596 . . . . 0.41999999999999998 109.391 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' VAL . . . . . 0.422 ' CG2' ' O ' ' B' ' 1' ' ' PHE . 7.2 m 43.16 -159.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-O 121.312 0.577 . . . . 0.13 111.533 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -152.84 -171.96 4.09 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.342 -0.849 . . . . 0.27000000000000002 109.589 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.434 ' HG3' ' CG1' ' A' ' 3' ' ' VAL . 11.0 tt0 -53.0 -34.98 58.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.473 -0.767 . . . . 0.20000000000000001 109.378 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -52.42 -22.17 4.43 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.409 -0.807 . . . . 0.14000000000000001 110.486 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 27.3 mt -118.27 -29.07 5.63 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.99 -1.069 . . . . 0.059999999999999998 109.9 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 34.9 t -66.42 -45.5 79.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.29 -0.881 . . . . 0.040000000000000001 109.752 -179.729 173.661 -172.64 131.925 103.039 2.022 104.871 82.104 -174.583 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.8 -31.41 75.62 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 24.3 p -56.05 -24.01 36.95 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.139 -1.212 . . . . 0.01 110.086 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -103.89 -18.62 14.55 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.177 -0.952 . . . . 0.11 110.832 -178.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.423 ' CD2' ' H5 ' ' A' ' 22' ' ' IPH . 56.7 mt -69.99 -34.28 73.14 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.382 -1.34 . . . . 0.01 107.382 178.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.431 ' CG2' HG22 ' D' ' 12' ' ' VAL . 28.2 m -65.22 -36.56 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-O 121.167 0.508 . . . . 0.0 110.046 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -54.91 -49.42 71.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.098 -1.001 . . . . 0.089999999999999997 109.846 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.97 -28.42 62.39 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.305 -0.872 . . . . 0.01 109.357 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 9.2 mt -59.37 -64.31 0.99 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.371 -0.83 . . . . 0.0 110.205 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . 0.481 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 1.7 p90 -71.17 -12.2 61.35 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.131 -1.028 . . . . 0.0 110.836 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 3.1 tt -74.02 -35.56 64.37 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 106.802 -1.555 . . . . 0.10000000000000001 106.802 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 97.7 t -77.26 -35.16 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.457 -0.942 . . . . 0.14000000000000001 108.457 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 48.8 m -74.15 -23.1 59.21 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.375 -0.828 . . . . 0.059999999999999998 109.485 179.598 -76.609 -89.424 173.549 103.93 2.019 104.235 76.709 -157.737 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.86 -116.18 5.24 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.478 -1.449 . . . . 0.13 109.478 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -83.64 -21.7 32.4 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.396 -1.061 . . . . 0.47999999999999998 109.711 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 31.9 mtm180 -59.39 177.43 0.19 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.071 -1.018 . . . . 0.28999999999999998 109.49 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.5 -176.33 14.5 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.479 -1.448 . . . . 0.01 109.479 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.481 ' CE1' ' HB3' ' B' ' 16' ' ' TYR . 3.8 p90 -158.74 163.43 36.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.145 -1.209 . . . . 0.0 109.794 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -109.25 122.73 47.95 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.206 -0.934 . . . . 0.33000000000000002 108.805 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -109.18 115.83 30.77 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.223 -0.923 . . . . 0.0 109.975 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 36.7 p -125.27 98.34 35.66 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.182 -0.948 . . . . 0.23000000000000001 109.467 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -78.94 59.46 7.37 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 121.324 1.35 . . . . 0.040000000000000001 109.848 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -159.99 75.56 0.61 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.36 -0.838 . . . . 0.40000000000000002 109.481 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 6.3 m . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.986 -1.007 . . . . 0.62 109.248 179.891 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.404 -1.478 . . . . 0.28999999999999998 109.404 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' ILE . . . . . 0.417 HG22 ' N ' ' C' ' 3' ' ' VAL . 10.5 tt -130.45 -42.58 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.124 -1.221 . . . . 0.050000000000000003 109.228 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . 0.435 ' CG1' ' HG3' ' D' ' 4' ' ' GLN . 2.8 t -65.91 -61.85 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.398 -0.814 . . . . 0.01 109.26 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.96 -17.89 28.78 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.354 -0.841 . . . . 0.45000000000000001 110.293 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -86.79 -35.11 19.32 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.895 -1.128 . . . . 0.23999999999999999 110.554 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 58.4 m -104.04 -23.39 13.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.871 -1.143 . . . . 0.01 110.958 -178.486 -54.797 -42.888 -97.212 104.447 2.022 104.032 129.237 -72.479 1 1 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' CYS . . . . . . . . . . . . . 48.0 t -76.63 -1.95 30.24 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.276 -0.969 . . . . 0.070000000000000007 110.267 179.342 -174.575 81.663 132.111 105.015 2.022 102.921 -172.364 173.641 1 1 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 16.5 p -86.68 -50.47 6.77 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.305 -1.497 . . . . 0.25 109.356 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -155.02 37.12 0.4 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.28999999999999998 109.659 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 3.5 mp 63.99 139.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-O 122.062 0.934 . . . . 0.10000000000000001 110.555 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 66.9 m -95.7 174.15 7.12 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.96 -0.756 . . . . 0.050000000000000003 108.96 179.439 -72.479 129.237 -97.212 104.032 2.022 104.447 -42.888 -54.797 1 1 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 19.0 m -83.34 164.54 19.95 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.331 -0.856 . . . . 0.27000000000000002 109.243 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 6.1 tt -58.67 -41.55 86.4 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.324 -0.86 . . . . 0.29999999999999999 110.367 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -68.56 -38.94 81.18 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.061 -1.024 . . . . 0.51000000000000001 110.162 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -58.37 -33.2 69.32 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.134 -0.979 . . . . 0.22 109.746 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 84.8 mt -72.12 -29.49 64.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 0.01 109.428 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -62.69 -31.19 72.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.294 -0.879 . . . . 0.26000000000000001 109.964 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 47.1 m-20 -58.59 -28.76 65.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -0.961 . . . . 0.41999999999999998 109.481 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -96.59 13.28 28.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.11 110.399 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 5.0 t -83.14 156.46 23.25 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.8 -1.188 . . . . 0.050000000000000003 109.672 -179.629 -157.824 77.085 173.834 104.06 2.017 103.866 -89.899 -76.356 1 1 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 C--N 1.303 -1.447 0 CA-C-O 118.02 -0.991 . . . . 0.40999999999999998 109.554 -179.926 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 1' ' ' PHE . . . . . 0.422 ' O ' ' CG2' ' D' ' 2' ' ' VAL . 20.8 t80 . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.323 -0.621 . . . . 0.41999999999999998 109.323 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 2' ' ' VAL . . . . . 0.422 ' CG2' ' O ' ' D' ' 1' ' ' PHE . 7.8 m 43.2 -159.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.696 -0.628 . . . . 0.12 111.444 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 3' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -152.58 -171.83 4.05 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.264 -0.898 . . . . 0.26000000000000001 109.644 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . 0.435 ' HG3' ' CG1' ' C' ' 3' ' ' VAL . 10.8 tt0 -53.22 -34.49 57.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.385 -0.822 . . . . 0.20000000000000001 109.395 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 5' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -52.9 -21.69 4.61 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.456 -0.778 . . . . 0.14000000000000001 110.583 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 6' ' ' LEU . . . . . . . . . . . . . 26.5 mt -118.7 -28.87 5.53 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.089 -1.007 . . . . 0.050000000000000003 109.899 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 7' ' ' CYS . . . . . . . . . . . . . 34.9 t -66.53 -45.46 79.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.173 -0.954 . . . . 0.040000000000000001 109.758 -179.746 173.641 -172.364 132.111 102.921 2.022 105.015 81.663 -174.575 1 1 . 1 . 001 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.92 -31.74 77.31 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 23.1 p -55.39 -24.32 29.25 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.987 -1.302 . . . . 0.01 110.039 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 10' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -103.85 -18.58 14.58 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.106 -0.996 . . . . 0.11 110.837 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . 0.424 ' CD2' ' H5 ' ' C' ' 22' ' ' IPH . 57.1 mt -69.97 -34.64 73.64 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.383 -1.34 . . . . 0.01 107.383 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 12' ' ' VAL . . . . . 0.431 HG22 ' CG2' ' B' ' 12' ' ' VAL . 27.6 m -65.05 -36.7 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.906 -0.496 . . . . 0.0 110.031 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -54.77 -49.42 70.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.083 -1.01 . . . . 0.089999999999999997 109.79 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.87 -28.68 62.65 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.302 -0.874 . . . . 0.01 109.413 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 9.3 mt -58.9 -64.6 0.88 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.362 -0.836 . . . . 0.0 110.173 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 16' ' ' TYR . . . . . 0.482 ' HB3' ' CE1' ' D' ' 24' ' ' PHE . 1.7 p90 -70.77 -12.69 61.7 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.131 -1.027 . . . . 0.0 110.93 -178.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 tt -73.66 -35.57 65.26 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 106.75 -1.574 . . . . 0.10000000000000001 106.75 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 99.4 t -77.14 -35.57 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.429 -0.952 . . . . 0.14000000000000001 108.429 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 19' ' ' CYS . . . . . . . . . . . . . 51.0 m -73.95 -22.84 59.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.416 -0.802 . . . . 0.059999999999999998 109.456 179.611 -76.356 -89.899 173.834 103.866 2.017 104.06 77.085 -157.824 1 1 . 1 . 001 nuclear orig full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.43 -115.73 5.19 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.553 -1.419 . . . . 0.13 109.553 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -83.7 -22.12 32.15 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.263 -1.14 . . . . 0.48999999999999999 109.764 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 31.9 mtm180 -59.03 177.53 0.15 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.083 -1.01 . . . . 0.28999999999999998 109.564 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.61 -176.29 14.48 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.54 -1.424 . . . . 0.01 109.54 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 24' ' ' PHE . . . . . 0.482 ' CE1' ' HB3' ' D' ' 16' ' ' TYR . 3.8 p90 -158.92 163.21 36.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.179 -1.189 . . . . 0.0 109.821 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -108.81 123.47 49.09 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.263 -0.898 . . . . 0.33000000000000002 108.619 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 26' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -109.84 115.94 30.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.36 -0.837 . . . . 0.0 109.719 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 36.8 p -125.47 98.55 34.7 Favored Pre-proline 0 N--CA 1.488 1.428 0 O-C-N 121.137 -0.977 . . . . 0.23000000000000001 109.46 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 28' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -78.99 59.5 7.4 Favored 'Trans proline' 0 C--O 1.216 -0.591 0 C-N-CA 121.345 1.363 . . . . 0.040000000000000001 109.91 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -160.02 75.64 0.61 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.41 -0.806 . . . . 0.40999999999999998 109.531 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.873 -1.06 . . . . 0.62 109.363 -179.99 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.539 -1.425 . . . . 0.28000000000000003 109.539 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 2' ' ' ILE . . . . . 0.417 HG22 ' N ' ' E' ' 3' ' ' VAL . 10.4 tt -130.6 -42.49 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -1.139 . . . . 0.050000000000000003 109.216 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 3' ' ' VAL . . . . . 0.431 ' CG1' ' HG3' ' F' ' 4' ' ' GLN . 2.8 t -65.76 -62.11 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.324 -0.86 . . . . 0.01 109.327 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.9 -17.83 27.79 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.339 -0.85 . . . . 0.46000000000000002 110.341 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -86.71 -35.51 19.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.995 -1.065 . . . . 0.23999999999999999 110.515 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 58.5 m -103.48 -23.89 13.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.943 -1.098 . . . . 0.0 110.957 -178.587 -54.825 -42.796 -97.243 104.528 2.023 104.035 129.417 -72.488 1 1 . 1 . 001 nuclear orig full ' E' E ' 7' ' ' CYS . . . . . . . . . . . . . 47.6 t -76.19 -2.07 29.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.126 -0.983 . . . . 0.070000000000000007 110.274 179.45 -174.647 81.733 132.048 104.804 2.024 102.944 -172.379 173.73 1 1 . 1 . 001 nuclear orig full ' E' E ' 8' ' ' THR . . . . . . . . . . . . . 16.1 p -86.51 -50.66 6.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.422 -1.424 . . . . 0.25 109.352 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 9' ' ' SER . . . . . . . . . . . . . 16.2 m -155.07 37.1 0.39 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.917 . . . . 0.28999999999999998 109.73 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 10' ' ' ILE . . . . . . . . . . . . . 3.5 mp 64.07 139.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 121.993 0.901 . . . . 0.10000000000000001 110.64 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 11' ' ' CYS . . . . . 0.403 ' N ' ' O1 ' ' E' ' 22' ' ' IPH . 66.8 m -95.03 174.07 7.26 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.976 -0.75 . . . . 0.050000000000000003 108.976 179.409 -72.488 129.417 -97.243 104.035 2.023 104.528 -42.796 -54.825 2 2 . 1 . 001 nuclear orig full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 19.4 m -83.36 165.11 19.55 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.26 -0.9 . . . . 0.27000000000000002 109.166 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 6.1 tt -59.1 -41.94 89.31 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.273 -0.892 . . . . 0.29999999999999999 110.274 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -68.09 -39.22 82.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.071 -1.018 . . . . 0.52000000000000002 110.178 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -58.01 -32.98 68.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.129 -0.982 . . . . 0.23000000000000001 109.761 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 16' ' ' LEU . . . . . . . . . . . . . 85.5 mt -72.43 -29.23 63.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.938 . . . . 0.01 109.468 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -62.77 -31.43 72.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.309 -0.869 . . . . 0.26000000000000001 109.949 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 48.4 m-20 -58.38 -28.78 65.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.203 -0.936 . . . . 0.41999999999999998 109.48 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 19' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -96.83 13.89 27.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -0.931 . . . . 0.11 110.296 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 5.0 t -83.68 156.76 22.48 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.875 -1.141 . . . . 0.050000000000000003 109.522 -179.593 -157.805 77.064 173.72 104.164 2.018 103.744 -89.885 -76.218 1 1 . 1 . 001 nuclear orig full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 C--N 1.301 -1.506 0 CA-C-O 117.934 -1.031 . . . . 0.42999999999999999 109.369 -179.91 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' F' F ' 1' ' ' PHE . . . . . 0.422 ' O ' ' CG2' ' F' ' 2' ' ' VAL . 20.8 t80 . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.308 -0.627 . . . . 0.41999999999999998 109.308 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 2' ' ' VAL . . . . . 0.422 ' CG2' ' O ' ' F' ' 1' ' ' PHE . 7.9 m 43.1 -158.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.748 -0.595 . . . . 0.13 111.38 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 3' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -153.43 -172.0 4.09 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.25 -0.906 . . . . 0.27000000000000002 109.572 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 4' ' ' GLN . . . . . 0.431 ' HG3' ' CG1' ' E' ' 3' ' ' VAL . 10.9 tt0 -53.03 -34.67 57.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.594 -0.691 . . . . 0.19 109.426 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -53.0 -21.68 4.74 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.438 -0.789 . . . . 0.14000000000000001 110.533 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 6' ' ' LEU . . . . . . . . . . . . . 26.5 mt -118.56 -28.96 5.55 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.098 -1.001 . . . . 0.059999999999999998 109.939 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 7' ' ' CYS . . . . . . . . . . . . . 35.1 t -66.71 -45.75 77.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.325 -0.859 . . . . 0.040000000000000001 109.654 -179.76 173.73 -172.379 132.048 102.944 2.024 104.804 81.733 -174.647 1 1 . 1 . 001 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.7 -31.09 74.12 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.594 -1.003 . . . . 0.0 110.594 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 22.3 p -56.22 -24.6 43.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.088 -1.242 . . . . 0.01 109.948 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -103.34 -18.56 14.8 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.184 -0.947 . . . . 0.11 110.893 -178.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . 0.431 ' CD2' ' H5 ' ' E' ' 22' ' ' IPH . 56.3 mt -69.89 -34.61 73.77 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.541 -1.281 . . . . 0.01 107.541 178.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 12' ' ' VAL . . . . . 0.433 HG22 ' CG2' ' H' ' 12' ' ' VAL . 28.6 m -64.95 -36.7 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.79 -0.569 . . . . 0.0 110.224 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 13' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -54.82 -49.39 71.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.065 -1.022 . . . . 0.089999999999999997 109.752 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.09 -28.1 62.09 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.273 -0.892 . . . . 0.01 109.403 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 15' ' ' LEU . . . . . . . . . . . . . 9.2 mt -59.52 -64.23 1.02 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.342 -0.849 . . . . 0.01 110.33 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 16' ' ' TYR . . . . . 0.484 ' HB3' ' CE1' ' F' ' 24' ' ' PHE . 1.7 p90 -71.07 -11.96 61.25 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.851 -178.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 17' ' ' LEU . . . . . . . . . . . . . 3.1 tt -74.17 -36.2 64.07 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 106.689 -1.597 . . . . 0.10000000000000001 106.689 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 18' ' ' VAL . . . . . . . . . . . . . 99.5 t -76.51 -35.44 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.486 -0.931 . . . . 0.14000000000000001 108.486 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 19' ' ' CYS . . . . . . . . . . . . . 51.7 m -74.03 -22.87 59.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.36 -0.838 . . . . 0.059999999999999998 109.636 179.607 -76.218 -89.885 173.72 103.744 2.018 104.164 77.064 -157.805 1 1 . 1 . 001 nuclear orig full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.13 -115.52 5.19 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.583 -1.407 . . . . 0.13 109.583 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -83.89 -21.9 31.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -1.138 . . . . 0.47999999999999998 109.712 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 22' ' ' ARG . . . . . . . . . . . . . 31.8 mtm180 -59.16 177.14 0.18 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.168 -0.958 . . . . 0.28999999999999998 109.394 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.4 -176.42 14.53 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.308 -1.517 . . . . 0.01 109.308 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 24' ' ' PHE . . . . . 0.484 ' CE1' ' HB3' ' F' ' 16' ' ' TYR . 3.9 p90 -158.63 163.32 37.03 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.13 -1.217 . . . . 0.0 109.876 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -108.96 122.93 48.28 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.26 -0.9 . . . . 0.32000000000000001 108.693 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -109.32 115.65 30.38 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.432 -0.792 . . . . 0.0 109.921 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 37.4 p -125.22 98.64 35.24 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.096 -1.002 . . . . 0.23000000000000001 109.597 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 28' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -79.26 59.34 7.36 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 121.394 1.396 . . . . 0.040000000000000001 109.752 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -159.84 75.31 0.62 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.283 -0.885 . . . . 0.40000000000000002 109.458 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.967 -1.016 . . . . 0.62 109.243 179.882 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.432 -1.467 . . . . 0.28999999999999998 109.432 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' G' G ' 2' ' ' ILE . . . . . 0.408 HG22 ' N ' ' G' ' 3' ' ' VAL . 10.3 tt -130.29 -42.46 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.251 -1.146 . . . . 0.050000000000000003 109.201 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 3' ' ' VAL . . . . . 0.428 ' CG1' ' HG3' ' H' ' 4' ' ' GLN . 2.8 t -66.08 -61.73 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 121.321 -0.862 . . . . 0.01 109.283 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.08 -17.73 28.68 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.299 -0.876 . . . . 0.46000000000000002 110.301 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -87.04 -35.16 18.91 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.844 -1.16 . . . . 0.25 110.417 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 58.6 m -103.75 -23.49 13.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.992 -1.067 . . . . 0.0 110.969 -178.594 -54.875 -42.765 -97.092 104.532 2.022 104.065 129.374 -72.647 1 1 . 1 . 001 nuclear orig full ' G' G ' 7' ' ' CYS . . . . . . . . . . . . . 48.4 t -76.58 -1.95 30.05 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.311 -0.956 . . . . 0.059999999999999998 110.364 179.461 -174.504 81.704 131.985 105.072 2.022 102.829 -172.522 173.692 1 1 . 1 . 001 nuclear orig full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 16.2 p -86.68 -50.55 6.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.452 -1.405 . . . . 0.23999999999999999 109.34 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 16.4 m -154.91 37.12 0.4 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.92 . . . . 0.28000000000000003 109.608 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 10' ' ' ILE . . . . . . . . . . . . . 3.6 mp 63.99 139.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 122.005 0.907 . . . . 0.10000000000000001 110.513 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 66.2 m -95.6 174.24 7.09 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.966 -0.753 . . . . 0.050000000000000003 108.966 179.419 -72.647 129.374 -97.092 104.065 2.022 104.532 -42.765 -54.875 1 1 . 1 . 001 nuclear orig full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 19.3 m -83.54 165.2 19.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.239 -0.913 . . . . 0.28000000000000003 109.111 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 6.1 tt -59.13 -41.83 89.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.273 -0.892 . . . . 0.29999999999999999 110.373 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -68.31 -38.86 82.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.088 -1.008 . . . . 0.53000000000000003 110.176 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -58.31 -33.08 69.09 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.133 -0.979 . . . . 0.23000000000000001 109.785 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 85.1 mt -72.2 -29.5 64.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.15 -0.969 . . . . 0.01 109.506 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -62.67 -31.43 72.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.26000000000000001 109.943 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -58.43 -28.58 65.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.40000000000000002 109.42 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 19' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -96.82 13.39 28.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.151 -0.968 . . . . 0.11 110.348 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 5.0 t -83.34 157.0 22.74 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.774 -1.203 . . . . 0.050000000000000003 109.587 -179.554 -157.761 76.762 173.745 104.191 2.019 103.928 -89.746 -76.385 1 1 . 1 . 001 nuclear orig full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 C--N 1.303 -1.429 0 CA-C-O 118.034 -0.984 . . . . 0.40999999999999998 109.547 -179.903 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' H' H ' 1' ' ' PHE . . . . . 0.421 ' O ' ' CG2' ' H' ' 2' ' ' VAL . 21.1 t80 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.328 -0.619 . . . . 0.41999999999999998 109.328 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 2' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' H' ' 1' ' ' PHE . 8.2 m 43.09 -159.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.68 -0.637 . . . . 0.12 111.44 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 3' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -152.67 -172.4 4.23 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.306 -0.871 . . . . 0.26000000000000001 109.772 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 4' ' ' GLN . . . . . 0.428 ' HG3' ' CG1' ' G' ' 3' ' ' VAL . 11.0 tt0 -52.55 -34.73 51.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.46 -0.775 . . . . 0.19 109.494 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -52.96 -21.52 4.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.341 -0.849 . . . . 0.14000000000000001 110.497 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 6' ' ' LEU . . . . . . . . . . . . . 27.2 mt -118.78 -28.55 5.57 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.052 -1.03 . . . . 0.050000000000000003 109.971 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 7' ' ' CYS . . . . . . . . . . . . . 35.0 t -66.95 -45.63 77.19 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.243 -0.911 . . . . 0.040000000000000001 109.66 -179.73 173.692 -172.522 131.985 102.829 2.022 105.072 81.704 -174.504 1 1 . 1 . 001 nuclear orig full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.7 -31.46 75.43 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 21.5 p -55.82 -24.37 35.83 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.935 -1.332 . . . . 0.01 109.908 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 10' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -103.61 -18.98 14.52 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.085 -1.009 . . . . 0.11 110.889 -178.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . 0.429 ' CD2' ' H5 ' ' G' ' 22' ' ' IPH . 55.9 mt -69.6 -34.84 74.69 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.409 -1.33 . . . . 0.01 107.409 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 12' ' ' VAL . . . . . 0.433 ' CG2' HG22 ' F' ' 12' ' ' VAL . 27.8 m -64.77 -37.11 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.873 -0.517 . . . . 0.0 110.128 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 13' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -54.58 -49.3 70.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.084 -1.01 . . . . 0.089999999999999997 109.875 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.0 -28.72 62.53 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.259 -0.9 . . . . 0.01 109.404 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 15' ' ' LEU . . . . . . . . . . . . . 9.2 mt -58.8 -64.74 0.83 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.286 -0.884 . . . . 0.0 110.282 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 16' ' ' TYR . . . . . 0.476 ' HB3' ' CE1' ' H' ' 24' ' ' PHE . 1.7 p90 -70.61 -12.6 61.66 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.143 -1.023 . . . . 0.0 110.865 -178.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 tt -73.56 -36.0 65.55 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 106.745 -1.576 . . . . 0.10000000000000001 106.745 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 18' ' ' VAL . . . . . . . . . . . . . 99.5 t -76.85 -35.31 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 108.539 -0.912 . . . . 0.14000000000000001 108.539 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 19' ' ' CYS . . . . . . . . . . . . . 50.9 m -74.02 -22.85 59.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.262 -0.899 . . . . 0.059999999999999998 109.481 179.547 -76.385 -89.746 173.745 103.928 2.019 104.191 76.762 -157.761 1 1 . 1 . 001 nuclear orig full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.31 -115.57 5.16 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.561 -1.416 . . . . 0.13 109.561 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -83.92 -21.67 31.8 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.309 -1.113 . . . . 0.47999999999999998 109.807 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 22' ' ' ARG . . . . . . . . . . . . . 31.7 mtm180 -59.34 177.33 0.19 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.125 -0.984 . . . . 0.28999999999999998 109.562 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.54 -176.85 14.67 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.581 -1.408 . . . . 0.01 109.581 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 24' ' ' PHE . . . . . 0.476 ' CE1' ' HB3' ' H' ' 16' ' ' TYR . 3.9 p90 -158.43 163.39 37.25 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.2 -1.177 . . . . 0.0 109.786 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -109.14 123.06 48.6 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.246 -0.908 . . . . 0.34000000000000002 108.702 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -109.55 115.66 30.33 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.366 -0.834 . . . . 0.0 109.834 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 27' ' ' THR . . . . . . . . . . . . . 36.4 p -125.3 98.39 35.5 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.159 -0.963 . . . . 0.23999999999999999 109.442 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 28' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.05 59.88 7.56 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 121.333 1.355 . . . . 0.040000000000000001 109.835 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -160.31 75.3 0.58 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.375 -0.828 . . . . 0.40999999999999998 109.431 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.949 -1.024 . . . . 0.62 109.369 179.88 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 N-CA-C 109.532 -1.427 . . . . 0.28999999999999998 109.532 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' I' I ' 2' ' ' ILE . . . . . 0.413 HG22 ' N ' ' I' ' 3' ' ' VAL . 10.4 tt -130.41 -42.33 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.192 -1.181 . . . . 0.050000000000000003 109.278 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 3' ' ' VAL . . . . . 0.428 ' CG1' ' HG3' ' J' ' 4' ' ' GLN . 2.8 t -66.0 -61.96 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 121.396 -0.815 . . . . 0.01 109.243 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.73 -18.0 27.76 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.36 -0.838 . . . . 0.46000000000000002 110.297 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -86.81 -35.47 19.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.874 -1.141 . . . . 0.23999999999999999 110.498 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 58.6 m -103.53 -23.49 13.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.896 -1.127 . . . . 0.01 110.959 -178.66 -54.866 -42.485 -97.48 104.518 2.023 104.012 129.157 -72.254 1 1 . 1 . 001 nuclear orig full ' I' I ' 7' ' ' CYS . . . . . . . . . . . . . 48.2 t -76.65 -1.54 28.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.182 -0.949 . . . . 0.070000000000000007 110.287 179.347 -174.534 81.725 132.409 104.818 2.022 102.974 -172.396 173.499 1 1 . 1 . 001 nuclear orig full ' I' I ' 8' ' ' THR . . . . . . . . . . . . . 16.0 p -86.98 -50.73 6.46 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.5 -1.375 . . . . 0.25 109.273 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 16.3 m -154.91 37.1 0.4 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.176 -0.952 . . . . 0.28999999999999998 109.653 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 10' ' ' ILE . . . . . . . . . . . . . 3.5 mp 64.13 139.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 122.001 0.905 . . . . 0.10000000000000001 110.615 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 67.6 m -95.27 174.21 7.16 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.986 -0.746 . . . . 0.050000000000000003 108.986 179.459 -72.254 129.157 -97.48 104.012 2.023 104.518 -42.485 -54.866 1 1 . 1 . 001 nuclear orig full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 18.6 m -83.47 164.65 19.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -0.923 . . . . 0.27000000000000002 109.165 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 6.0 tt -58.7 -41.57 86.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.377 -0.827 . . . . 0.29999999999999999 110.337 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -68.68 -38.85 80.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.085 -1.01 . . . . 0.51000000000000001 110.136 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -58.29 -33.26 69.25 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.243 -0.911 . . . . 0.22 109.745 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 87.7 mt -72.05 -29.48 64.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.162 -0.961 . . . . 0.01 109.421 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -62.67 -31.14 71.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.333 -0.854 . . . . 0.27000000000000002 109.914 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -58.72 -28.85 66.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.193 -0.942 . . . . 0.41999999999999998 109.412 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 19' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -96.48 13.41 28.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 0.11 110.388 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 4.9 t -83.3 156.6 22.99 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.769 -1.207 . . . . 0.050000000000000003 109.622 -179.598 -157.649 77.17 173.7 104.136 2.018 103.758 -90.056 -76.247 1 1 . 1 . 001 nuclear orig full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 t30 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.02 -0.99 . . . . 0.40999999999999998 109.501 -179.977 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' J' J ' 1' ' ' PHE . . . . . 0.421 ' O ' ' CG2' ' J' ' 2' ' ' VAL . 20.8 t80 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.328 -0.619 . . . . 0.41999999999999998 109.328 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 2' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' J' ' 1' ' ' PHE . 7.3 m 43.31 -159.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 121.764 -0.585 . . . . 0.13 111.422 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 3' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -152.65 -172.09 4.13 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.363 -0.836 . . . . 0.27000000000000002 109.791 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 4' ' ' GLN . . . . . 0.428 ' HG3' ' CG1' ' I' ' 3' ' ' VAL . 10.9 tt0 -52.96 -34.41 55.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.504 -0.747 . . . . 0.20000000000000001 109.422 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 5' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -53.24 -21.27 5.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.408 -0.807 . . . . 0.14000000000000001 110.516 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 6' ' ' LEU . . . . . . . . . . . . . 26.7 mt -119.09 -29.05 5.35 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.225 -0.922 . . . . 0.059999999999999998 109.92 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 7' ' ' CYS . . . . . . . . . . . . . 34.5 t -66.41 -45.53 79.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.040000000000000001 109.728 -179.758 173.499 -172.396 132.409 102.974 2.022 104.818 81.725 -174.534 1 1 . 1 . 001 nuclear orig full ' J' J ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.89 -31.58 76.61 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 23.9 p -55.68 -24.27 33.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.946 -1.326 . . . . 0.01 110.016 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 10' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -103.89 -18.49 14.6 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.211 -0.931 . . . . 0.11 110.899 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 11' ' ' LEU . . . . . 0.428 ' CD2' ' H5 ' ' I' ' 22' ' ' IPH . 56.7 mt -70.05 -34.3 73.05 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.419 -1.326 . . . . 0.01 107.419 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 12' ' ' VAL . . . . . 0.429 ' CG2' HG22 ' L' ' 12' ' ' VAL . 27.8 m -65.22 -37.05 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.783 -0.573 . . . . 0.0 110.05 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 13' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -54.64 -48.77 71.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.04 -1.037 . . . . 0.10000000000000001 109.836 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.63 -28.47 61.81 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.224 -0.922 . . . . 0.01 109.288 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 15' ' ' LEU . . . . . . . . . . . . . 9.3 mt -58.94 -64.33 0.98 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.361 -0.837 . . . . 0.0 110.326 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 16' ' ' TYR . . . . . 0.478 ' HB3' ' CE1' ' J' ' 24' ' ' PHE . 1.8 p90 -71.04 -12.52 61.57 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.129 -1.029 . . . . 0.0 110.838 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 tt -73.89 -35.39 64.67 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 106.822 -1.547 . . . . 0.10000000000000001 106.822 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 18' ' ' VAL . . . . . . . . . . . . . 96.6 t -77.25 -35.66 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 108.279 -1.008 . . . . 0.13 108.279 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 19' ' ' CYS . . . . . . . . . . . . . 51.6 m -73.87 -22.7 59.64 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.372 -0.83 . . . . 0.059999999999999998 109.509 179.614 -76.247 -90.056 173.7 103.758 2.018 104.136 77.17 -157.649 1 1 . 1 . 001 nuclear orig full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.15 -115.44 5.15 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.593 -1.403 . . . . 0.13 109.593 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -84.0 -21.93 31.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.211 -1.17 . . . . 0.47999999999999998 109.716 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 22' ' ' ARG . . . . . . . . . . . . . 31.5 mtm180 -59.07 177.46 0.16 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.071 -1.018 . . . . 0.28999999999999998 109.526 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.5 -176.16 14.44 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.459 -1.457 . . . . 0.01 109.459 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 24' ' ' PHE . . . . . 0.478 ' CE1' ' HB3' ' J' ' 16' ' ' TYR . 3.9 p90 -158.98 163.15 36.71 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.257 -1.143 . . . . 0.0 109.851 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -108.94 123.03 48.46 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.292 -0.88 . . . . 0.33000000000000002 108.673 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 26' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -109.47 115.54 30.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.444 -0.785 . . . . 0.0 109.866 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 27' ' ' THR . . . . . . . . . . . . . 36.2 p -125.24 98.55 35.35 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.157 -0.965 . . . . 0.23999999999999999 109.459 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 28' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.05 59.68 7.49 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 121.282 1.321 . . . . 0.050000000000000003 109.963 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -160.18 75.31 0.59 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.365 -0.834 . . . . 0.40000000000000002 109.476 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 6.3 m . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.011 -0.995 . . . . 0.62 109.409 179.935 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.409 -1.476 . . . . 0.28999999999999998 109.409 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' K' K ' 2' ' ' ILE . . . . . 0.408 HG22 ' N ' ' K' ' 3' ' ' VAL . 10.3 tt -130.38 -42.47 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -1.195 . . . . 0.050000000000000003 109.189 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 3' ' ' VAL . . . . . 0.433 ' CG1' ' HG3' ' L' ' 4' ' ' GLN . 2.8 t -65.96 -61.88 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.371 -0.831 . . . . 0.01 109.271 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.09 -17.53 27.01 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.224 -0.923 . . . . 0.46000000000000002 110.333 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -87.09 -35.39 18.72 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.883 -1.135 . . . . 0.23999999999999999 110.495 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 58.4 m -103.68 -23.47 13.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.051 -1.03 . . . . 0.01 110.985 -178.653 -54.783 -42.815 -97.028 104.561 2.021 104.04 129.17 -72.535 1 1 . 1 . 001 nuclear orig full ' K' K ' 7' ' ' CYS . . . . . . . . . . . . . 48.5 t -76.7 -1.57 28.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.102 -0.999 . . . . 0.059999999999999998 110.289 179.359 -174.463 81.965 131.997 105.042 2.022 102.882 -172.541 173.841 1 1 . 1 . 001 nuclear orig full ' K' K ' 8' ' ' THR . . . . . . . . . . . . . 15.7 p -86.68 -50.57 6.69 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.435 -1.416 . . . . 0.25 109.216 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 9' ' ' SER . . . . . . . . . . . . . 16.4 m -155.04 36.63 0.39 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.197 -0.94 . . . . 0.29999999999999999 109.682 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 10' ' ' ILE . . . . . . . . . . . . . 3.6 mp 64.57 138.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 122.069 0.937 . . . . 0.11 110.743 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 66.7 m -94.86 174.46 7.09 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.001 -0.741 . . . . 0.050000000000000003 109.001 179.407 -72.535 129.17 -97.028 104.04 2.021 104.561 -42.815 -54.783 1 1 . 1 . 001 nuclear orig full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 19.0 m -83.52 165.08 19.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.191 -0.943 . . . . 0.27000000000000002 109.102 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 6.2 tt -58.99 -41.92 88.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.29999999999999999 110.315 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -68.23 -39.45 82.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.005 -1.06 . . . . 0.51000000000000001 110.077 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -57.78 -33.25 68.34 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.129 -0.982 . . . . 0.22 109.753 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 16' ' ' LEU . . . . . . . . . . . . . 86.0 mt -72.1 -29.62 64.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.185 -0.947 . . . . 0.01 109.477 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -62.54 -31.28 72.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.26000000000000001 109.9 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -58.71 -28.37 65.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.159 -0.963 . . . . 0.41999999999999998 109.445 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 19' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -96.9 13.62 28.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.938 . . . . 0.11 110.296 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 4.9 t -83.44 156.88 22.69 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.755 -1.216 . . . . 0.050000000000000003 109.631 -179.553 -157.625 77.204 174.002 104.158 2.019 103.818 -90.005 -76.264 1 1 . 1 . 001 nuclear orig full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 C--N 1.302 -1.467 0 CA-C-O 117.947 -1.025 . . . . 0.40999999999999998 109.403 -179.881 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' L' L ' 1' ' ' PHE . . . . . 0.42 ' O ' ' CG2' ' L' ' 2' ' ' VAL . 21.2 t80 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.383 -0.599 . . . . 0.41999999999999998 109.383 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 2' ' ' VAL . . . . . 0.42 ' CG2' ' O ' ' L' ' 1' ' ' PHE . 7.5 m 43.04 -158.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 CA-C-O 121.352 0.596 . . . . 0.12 111.408 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 3' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -153.25 -172.19 4.16 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.248 -0.908 . . . . 0.26000000000000001 109.664 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 4' ' ' GLN . . . . . 0.433 ' HG3' ' CG1' ' K' ' 3' ' ' VAL . 10.8 tt0 -52.79 -34.87 55.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.53 -0.731 . . . . 0.20000000000000001 109.448 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 5' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -52.84 -21.75 4.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.405 -0.81 . . . . 0.14000000000000001 110.556 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 6' ' ' LEU . . . . . . . . . . . . . 25.7 mt -118.51 -29.02 5.56 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.061 -1.024 . . . . 0.059999999999999998 109.836 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 7' ' ' CYS . . . . . . . . . . . . . 35.4 t -66.54 -45.49 79.26 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.305 -0.872 . . . . 0.040000000000000001 109.752 -179.701 173.841 -172.541 131.997 102.882 2.022 105.042 81.965 -174.463 1 1 . 1 . 001 nuclear orig full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.03 -31.12 75.44 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 23.3 p -56.05 -24.41 39.46 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.07 -1.253 . . . . 0.01 109.965 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 10' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -103.51 -18.62 14.7 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.064 -1.022 . . . . 0.11 110.832 -178.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 11' ' ' LEU . . . . . 0.423 ' CD2' ' H5 ' ' K' ' 22' ' ' IPH . 55.7 mt -69.78 -34.17 73.38 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.414 -1.328 . . . . 0.01 107.414 178.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 12' ' ' VAL . . . . . 0.429 HG22 ' CG2' ' J' ' 12' ' ' VAL . 27.5 m -65.66 -36.62 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.715 -0.616 . . . . 0.0 110.134 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 13' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -54.68 -49.69 70.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.144 -0.972 . . . . 0.089999999999999997 109.774 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.72 -28.87 62.92 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.32 -0.863 . . . . 0.01 109.235 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 15' ' ' LEU . . . . . . . . . . . . . 9.1 mt -58.87 -64.17 1.03 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.361 -0.837 . . . . 0.0 110.257 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 16' ' ' TYR . . . . . 0.483 ' HB3' ' CE1' ' L' ' 24' ' ' PHE . 1.7 p90 -71.18 -12.12 61.31 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.911 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 tt -74.04 -35.83 64.35 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 106.763 -1.569 . . . . 0.10000000000000001 106.763 176.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 18' ' ' VAL . . . . . . . . . . . . . 98.3 t -76.85 -35.31 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.391 -0.966 . . . . 0.13 108.391 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 19' ' ' CYS . . . . . . . . . . . . . 51.5 m -74.32 -22.39 59.28 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.385 -0.822 . . . . 0.059999999999999998 109.556 179.636 -76.264 -90.005 174.002 103.818 2.019 104.158 77.204 -157.625 1 1 . 1 . 001 nuclear orig full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.84 -115.37 5.21 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.636 -1.386 . . . . 0.13 109.636 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -84.0 -22.13 31.45 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.244 -1.151 . . . . 0.48999999999999999 109.744 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 22' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -59.07 177.58 0.16 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.29999999999999999 109.54 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.75 -176.52 14.55 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.464 -1.455 . . . . 0.01 109.464 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 24' ' ' PHE . . . . . 0.483 ' CE1' ' HB3' ' L' ' 16' ' ' TYR . 3.7 p90 -158.67 163.6 36.72 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.081 -1.247 . . . . 0.0 109.859 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -109.29 122.67 47.85 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.278 -0.889 . . . . 0.33000000000000002 108.733 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -109.08 115.73 30.6 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.414 -0.804 . . . . 0.0 109.84 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 27' ' ' THR . . . . . . . . . . . . . 36.4 p -125.3 98.57 35.16 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.088 -1.007 . . . . 0.23000000000000001 109.45 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 28' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.0 59.54 7.42 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 121.355 1.37 . . . . 0.040000000000000001 109.865 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -160.06 75.48 0.6 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.389 -0.819 . . . . 0.40000000000000002 109.502 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.903 -1.046 . . . . 0.62 109.469 179.899 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' IPH . . . . . 0.423 ' H5 ' ' CD2' ' B' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' IPH . . . . . 0.424 ' H5 ' ' CD2' ' D' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 22' ' ' IPH . . . . . 0.431 ' H5 ' ' CD2' ' F' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 22' ' ' IPH . . . . . 0.429 ' H5 ' ' CD2' ' H' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 22' ' ' IPH . . . . . 0.428 ' H5 ' ' CD2' ' J' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 22' ' ' IPH . . . . . 0.423 ' H5 ' ' CD2' ' L' ' 11' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.489 -1.444 . . . . 0.29 109.489 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.652 HD12 ' CG ' ' A' ' 19' ' ' TYR . 10.5 tt -130.31 -42.64 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.256 -1.143 . . . . 0.05 109.29 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.705 HG11 ' HG3' ' B' ' 4' ' ' GLN . 2.8 t -65.77 -62.01 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.314 -0.866 . . . . 0.01 109.249 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.403 ' O ' HG23 ' A' ' 8' ' ' THR . 0.8 OUTLIER -58.78 -18.01 28.29 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.397 -0.814 . . . . 0.46 110.24 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -86.76 -35.15 19.35 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.942 -1.099 . . . . 0.24 110.537 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.7 m -103.91 -23.77 13.33 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.976 -1.078 . . . . 0.0 111.015 -178.492 -54.903 -42.76 -97.206 104.568 2.023 104.076 129.264 -72.529 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.413 ' HB2' HD11 ' B' ' 11' ' ' LEU . 48.0 t -76.29 -2.39 31.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.204 -0.935 . . . . 0.07 110.264 179.338 -174.583 82.104 131.925 104.871 2.022 103.039 -172.64 173.661 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 4' ' ' GLU . 15.7 p -86.15 -50.33 7.08 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.473 -1.392 . . . . 0.25 109.305 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.401 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 16.2 m -155.24 36.99 0.39 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.275 -0.891 . . . . 0.29 109.777 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.641 HG23 ' C2 ' ' A' ' 22' ' ' IPH . 3.6 mp 64.22 138.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 122.003 0.906 . . . . 0.1 110.701 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 66.7 m -95.05 174.41 7.09 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.031 -0.729 . . . . 0.05 109.031 179.466 -72.529 129.264 -97.206 104.076 2.023 104.568 -42.76 -54.903 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.1 m -83.61 164.27 19.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.895 . . . . 0.27 109.285 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.1 tt -58.35 -41.67 85.21 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.329 -0.857 . . . . 0.3 110.403 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -68.44 -38.99 81.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.026 -1.046 . . . . 0.52 110.186 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -58.38 -33.1 69.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.165 -0.959 . . . . 0.23 109.666 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.43 ' HA ' HD23 ' A' ' 16' ' ' LEU . 85.1 mt -72.03 -29.53 64.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.228 -0.92 . . . . 0.01 109.487 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -62.76 -31.11 72.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.863 . . . . 0.26 109.922 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 -58.74 -28.34 65.79 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.088 -1.007 . . . . 0.42 109.454 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.652 ' CG ' HD12 ' A' ' 2' ' ' ILE . 36.7 m-85 -96.92 13.18 29.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.11 110.402 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.0 t -83.06 157.04 23.03 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.836 -1.165 . . . . 0.05 109.593 -179.497 -157.737 76.709 173.549 104.235 2.019 103.93 -89.424 -76.609 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 C--N 1.302 -1.494 0 CA-C-O 117.915 -1.041 . . . . 0.41 109.554 -179.861 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.547 ' O ' HG22 ' B' ' 2' ' ' VAL . 20.8 t80 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.391 -0.596 . . . . 0.42 109.391 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' VAL . . . . . 0.547 HG22 ' O ' ' B' ' 1' ' ' PHE . 7.2 m 43.16 -159.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-O 121.312 0.577 . . . . 0.13 111.533 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ASN . . . . . 0.473 ' H ' HD11 ' I' ' 10' ' ' ILE . 2.2 t-20 -152.84 -171.96 4.09 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.342 -0.849 . . . . 0.27 109.589 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.705 ' HG3' HG11 ' A' ' 3' ' ' VAL . 11.0 tt0 -53.0 -34.98 58.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.473 -0.767 . . . . 0.2 109.378 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' HIS . . . . . 0.415 ' CD2' HG21 ' I' ' 10' ' ' ILE . 41.9 t60 -52.42 -22.17 4.43 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.409 -0.807 . . . . 0.14 110.486 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.849 HD21 ' H4 ' ' I' ' 22' ' ' IPH . 27.3 mt -118.27 -29.07 5.63 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.99 -1.069 . . . . 0.06 109.9 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' CYS . . . . . 0.406 ' HB3' ' HA ' ' B' ' 4' ' ' GLN . 34.9 t -66.42 -45.5 79.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.29 -0.881 . . . . 0.04 109.752 -179.729 173.661 -172.64 131.925 103.039 2.022 104.871 82.104 -174.583 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' GLY . . . . . 0.402 ' HA3' ' OH ' ' B' ' 26' ' ' TYR . . . -60.8 -31.41 75.62 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 24.3 p -56.05 -24.01 36.95 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.139 -1.212 . . . . 0.01 110.086 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' HIS . . . . . 0.413 ' HA ' ' HG3' ' B' ' 13' ' ' GLU . 99.3 m-70 -103.89 -18.62 14.55 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.177 -0.952 . . . . 0.11 110.832 -178.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.636 HD23 ' H5 ' ' A' ' 22' ' ' IPH . 56.7 mt -69.99 -34.28 73.14 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.382 -1.34 . . . . 0.01 107.382 178.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.583 HG21 ' CG2' ' D' ' 12' ' ' VAL . 28.2 m -65.22 -36.56 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-O 121.167 0.508 . . . . 0.0 110.046 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.413 ' HG3' ' HA ' ' B' ' 10' ' ' HIS . 26.2 mt-10 -54.91 -49.42 71.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.098 -1.001 . . . . 0.09 109.846 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.489 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -72.97 -28.42 62.39 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.305 -0.872 . . . . 0.01 109.357 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.402 ' HB2' ' HA ' ' B' ' 12' ' ' VAL . 9.2 mt -59.37 -64.31 0.99 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.371 -0.83 . . . . 0.0 110.205 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.501 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 1.7 p90 -71.17 -12.2 61.35 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.131 -1.028 . . . . 0.0 110.836 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.616 HD11 ' H3 ' ' G' ' 22' ' ' IPH . 3.1 tt -74.02 -35.56 64.37 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 106.802 -1.555 . . . . 0.1 106.802 176.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.489 HG23 ' O ' ' B' ' 14' ' ' ALA . 97.7 t -77.26 -35.16 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.457 -0.942 . . . . 0.14 108.457 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' CYS . . . . . 0.41 ' HB2' ' HA ' ' B' ' 16' ' ' TYR . 48.8 m -74.15 -23.1 59.21 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.375 -0.828 . . . . 0.06 109.485 179.598 -76.609 -89.424 173.549 103.93 2.019 104.235 76.709 -157.737 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.86 -116.18 5.24 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.478 -1.449 . . . . 0.13 109.478 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -83.64 -21.7 32.4 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.396 -1.061 . . . . 0.48 109.711 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 31.9 mtm180 -59.39 177.43 0.19 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.071 -1.018 . . . . 0.29 109.49 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' D' ' 27' ' ' THR . . . -125.5 -176.33 14.5 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.479 -1.448 . . . . 0.01 109.479 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.501 ' CE1' ' HB3' ' B' ' 16' ' ' TYR . 3.8 p90 -158.74 163.43 36.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.145 -1.209 . . . . 0.0 109.794 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -109.25 122.73 47.95 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.206 -0.934 . . . . 0.33 108.805 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.402 ' OH ' ' HA3' ' B' ' 8' ' ' GLY . 52.8 t80 -109.18 115.83 30.77 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.223 -0.923 . . . . 0.0 109.975 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.421 ' HA ' ' HA3' ' D' ' 23' ' ' GLY . 36.7 p -125.27 98.34 35.66 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.182 -0.948 . . . . 0.23 109.467 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' PRO . . . . . 0.533 ' HA ' HG21 ' A' ' 3' ' ' VAL . 36.7 Cg_endo -78.94 59.46 7.37 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 121.324 1.35 . . . . 0.04 109.848 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -159.99 75.56 0.61 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.36 -0.838 . . . . 0.4 109.481 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 6.3 m . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.986 -1.007 . . . . 0.62 109.248 179.891 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.404 -1.478 . . . . 0.29 109.404 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 2' ' ' ILE . . . . . 0.645 HD12 ' CG ' ' C' ' 19' ' ' TYR . 10.5 tt -130.45 -42.58 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.124 -1.221 . . . . 0.05 109.228 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 3' ' ' VAL . . . . . 0.695 HG11 ' HG3' ' D' ' 4' ' ' GLN . 2.8 t -65.91 -61.85 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.398 -0.814 . . . . 0.01 109.26 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.96 -17.89 28.78 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.354 -0.841 . . . . 0.45 110.293 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -86.79 -35.11 19.32 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.895 -1.128 . . . . 0.24 110.554 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 58.4 m -104.04 -23.39 13.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.871 -1.143 . . . . 0.01 110.958 -178.486 -54.797 -42.888 -97.212 104.447 2.022 104.032 129.237 -72.479 1 1 . 1 . 001 nuclear build full ' C' C ' 7' ' ' CYS . . . . . 0.426 ' HB2' HD11 ' D' ' 11' ' ' LEU . 48.0 t -76.63 -1.95 30.24 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.276 -0.969 . . . . 0.07 110.267 179.342 -174.575 81.663 132.111 105.015 2.022 102.921 -172.364 173.641 2 2 . 1 . 001 nuclear build full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 16.5 p -86.68 -50.47 6.77 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.305 -1.497 . . . . 0.25 109.356 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 9' ' ' SER . . . . . 0.404 ' O ' ' HB ' ' C' ' 10' ' ' ILE . 16.5 m -155.02 37.12 0.4 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.29 109.659 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 10' ' ' ILE . . . . . 0.636 HG23 ' C2 ' ' C' ' 22' ' ' IPH . 3.5 mp 63.99 139.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-O 122.062 0.934 . . . . 0.1 110.555 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 66.9 m -95.7 174.15 7.12 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.96 -0.756 . . . . 0.05 108.96 179.439 -72.479 129.237 -97.212 104.032 2.022 104.447 -42.888 -54.797 1 1 . 1 . 001 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 19.0 m -83.34 164.54 19.95 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.331 -0.856 . . . . 0.27 109.243 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 6.1 tt -58.67 -41.55 86.4 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.324 -0.86 . . . . 0.3 110.367 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -68.56 -38.94 81.18 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.061 -1.024 . . . . 0.51 110.162 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -58.37 -33.2 69.32 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.134 -0.979 . . . . 0.22 109.746 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 84.8 mt -72.12 -29.49 64.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 0.01 109.428 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -62.69 -31.19 72.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.294 -0.879 . . . . 0.26 109.964 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 47.1 m-20 -58.59 -28.76 65.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -0.961 . . . . 0.42 109.481 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 19' ' ' TYR . . . . . 0.645 ' CG ' HD12 ' C' ' 2' ' ' ILE . 36.9 m-85 -96.59 13.28 28.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.11 110.399 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 5.0 t -83.14 156.46 23.25 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.8 -1.188 . . . . 0.05 109.672 -179.629 -157.824 77.085 173.834 104.06 2.017 103.866 -89.899 -76.356 1 1 . 1 . 001 nuclear build full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 C--N 1.303 -1.447 0 CA-C-O 118.02 -0.991 . . . . 0.41 109.554 -179.926 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 1' ' ' PHE . . . . . 0.546 ' O ' HG22 ' D' ' 2' ' ' VAL . 20.8 t80 . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.323 -0.621 . . . . 0.42 109.323 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 2' ' ' VAL . . . . . 0.546 HG22 ' O ' ' D' ' 1' ' ' PHE . 7.8 m 43.2 -159.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.696 -0.628 . . . . 0.12 111.444 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 3' ' ' ASN . . . . . 0.437 ' H ' HD11 ' G' ' 10' ' ' ILE . 2.2 t-20 -152.58 -171.83 4.05 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.264 -0.898 . . . . 0.26 109.644 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 4' ' ' GLN . . . . . 0.695 ' HG3' HG11 ' C' ' 3' ' ' VAL . 10.8 tt0 -53.22 -34.49 57.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.385 -0.822 . . . . 0.2 109.395 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 5' ' ' HIS . . . . . 0.423 ' CD2' HG21 ' G' ' 10' ' ' ILE . 42.9 t60 -52.9 -21.69 4.61 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.456 -0.778 . . . . 0.14 110.583 -179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 6' ' ' LEU . . . . . 0.858 HD21 ' H4 ' ' G' ' 22' ' ' IPH . 26.5 mt -118.7 -28.87 5.53 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.089 -1.007 . . . . 0.05 109.899 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 7' ' ' CYS . . . . . 0.421 ' HB3' ' HA ' ' D' ' 4' ' ' GLN . 34.9 t -66.53 -45.46 79.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.173 -0.954 . . . . 0.04 109.758 -179.746 173.641 -172.364 132.111 102.921 2.022 105.015 81.663 -174.575 2 2 . 1 . 001 nuclear build full ' D' D ' 8' ' ' GLY . . . . . 0.401 ' HA3' ' OH ' ' D' ' 26' ' ' TYR . . . -60.92 -31.74 77.31 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 23.1 p -55.39 -24.32 29.25 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.987 -1.302 . . . . 0.01 110.039 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 10' ' ' HIS . . . . . 0.402 ' HA ' ' HG3' ' D' ' 13' ' ' GLU . 99.3 m-70 -103.85 -18.58 14.58 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.106 -0.996 . . . . 0.11 110.837 -178.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 11' ' ' LEU . . . . . 0.639 HD23 ' H5 ' ' C' ' 22' ' ' IPH . 57.1 mt -69.97 -34.64 73.64 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.383 -1.34 . . . . 0.01 107.383 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 12' ' ' VAL . . . . . 0.583 ' CG2' HG21 ' B' ' 12' ' ' VAL . 27.6 m -65.05 -36.7 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.906 -0.496 . . . . 0.0 110.031 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 13' ' ' GLU . . . . . 0.408 ' N ' HG23 ' D' ' 12' ' ' VAL . 26.3 mt-10 -54.77 -49.42 70.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.083 -1.01 . . . . 0.09 109.79 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 14' ' ' ALA . . . . . 0.488 ' O ' HG23 ' D' ' 18' ' ' VAL . . . -72.87 -28.68 62.65 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.302 -0.874 . . . . 0.01 109.413 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.401 ' HB2' ' HA ' ' D' ' 12' ' ' VAL . 9.3 mt -58.9 -64.6 0.88 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.362 -0.836 . . . . 0.0 110.173 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 16' ' ' TYR . . . . . 0.504 ' HB3' ' CE1' ' D' ' 24' ' ' PHE . 1.7 p90 -70.77 -12.69 61.7 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.131 -1.027 . . . . 0.0 110.93 -178.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 17' ' ' LEU . . . . . 0.598 HD11 ' H3 ' ' I' ' 22' ' ' IPH . 3.2 tt -73.66 -35.57 65.26 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 106.75 -1.574 . . . . 0.1 106.75 176.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 18' ' ' VAL . . . . . 0.488 HG23 ' O ' ' D' ' 14' ' ' ALA . 99.4 t -77.14 -35.57 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.429 -0.952 . . . . 0.14 108.429 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 19' ' ' CYS . . . . . 0.414 ' HB2' ' HA ' ' D' ' 16' ' ' TYR . 51.0 m -73.95 -22.84 59.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.416 -0.802 . . . . 0.06 109.456 179.611 -76.356 -89.899 173.834 103.866 2.017 104.06 77.085 -157.824 2 2 . 1 . 001 nuclear build full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.43 -115.73 5.19 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.553 -1.419 . . . . 0.13 109.553 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -83.7 -22.12 32.15 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.263 -1.14 . . . . 0.49 109.764 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 31.9 mtm180 -59.03 177.53 0.15 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.083 -1.01 . . . . 0.29 109.564 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 23' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' B' ' 27' ' ' THR . . . -125.61 -176.29 14.48 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.54 -1.424 . . . . 0.01 109.54 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 24' ' ' PHE . . . . . 0.504 ' CE1' ' HB3' ' D' ' 16' ' ' TYR . 3.8 p90 -158.92 163.21 36.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.179 -1.189 . . . . 0.0 109.821 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -108.81 123.47 49.09 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.263 -0.898 . . . . 0.33 108.619 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 26' ' ' TYR . . . . . 0.401 ' OH ' ' HA3' ' D' ' 8' ' ' GLY . 53.4 t80 -109.84 115.94 30.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.36 -0.837 . . . . 0.0 109.719 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 27' ' ' THR . . . . . 0.431 ' HA ' ' HA3' ' B' ' 23' ' ' GLY . 36.8 p -125.47 98.55 34.7 Favored Pre-proline 0 N--CA 1.488 1.428 0 O-C-N 121.137 -0.977 . . . . 0.23 109.46 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 28' ' ' PRO . . . . . 0.538 ' HA ' HG21 ' C' ' 3' ' ' VAL . 36.7 Cg_endo -78.99 59.5 7.4 Favored 'Trans proline' 0 C--O 1.216 -0.591 0 C-N-CA 121.345 1.363 . . . . 0.04 109.91 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -160.02 75.64 0.61 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.41 -0.806 . . . . 0.41 109.531 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.873 -1.06 . . . . 0.62 109.363 -179.99 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.539 -1.425 . . . . 0.28 109.539 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 2' ' ' ILE . . . . . 0.643 HD12 ' CG ' ' E' ' 19' ' ' TYR . 10.4 tt -130.6 -42.49 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -1.139 . . . . 0.05 109.216 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 3' ' ' VAL . . . . . 0.693 HG11 ' HG3' ' F' ' 4' ' ' GLN . 2.8 t -65.76 -62.11 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.324 -0.86 . . . . 0.01 109.327 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 4' ' ' GLU . . . . . 0.409 ' O ' HG23 ' E' ' 8' ' ' THR . 0.8 OUTLIER -58.9 -17.83 27.79 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.339 -0.85 . . . . 0.46 110.341 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -86.71 -35.51 19.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.995 -1.065 . . . . 0.24 110.515 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 58.5 m -103.48 -23.89 13.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.943 -1.098 . . . . 0.0 110.957 -178.587 -54.825 -42.796 -97.243 104.528 2.023 104.035 129.417 -72.488 1 1 . 1 . 001 nuclear build full ' E' E ' 7' ' ' CYS . . . . . 0.421 ' HB2' HD11 ' F' ' 11' ' ' LEU . 47.6 t -76.19 -2.07 29.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.126 -0.983 . . . . 0.07 110.274 179.45 -174.647 81.733 132.048 104.804 2.024 102.944 -172.379 173.73 2 2 . 1 . 001 nuclear build full ' E' E ' 8' ' ' THR . . . . . 0.409 HG23 ' O ' ' E' ' 4' ' ' GLU . 16.1 p -86.51 -50.66 6.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.422 -1.424 . . . . 0.25 109.352 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 9' ' ' SER . . . . . 0.405 ' O ' ' HB ' ' E' ' 10' ' ' ILE . 16.2 m -155.07 37.1 0.39 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.917 . . . . 0.29 109.73 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 10' ' ' ILE . . . . . 0.628 HG23 ' C2 ' ' E' ' 22' ' ' IPH . 3.5 mp 64.07 139.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 121.993 0.901 . . . . 0.1 110.64 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 66.8 m -95.03 174.07 7.26 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.976 -0.75 . . . . 0.05 108.976 179.409 -72.488 129.417 -97.243 104.035 2.023 104.528 -42.796 -54.825 1 1 . 1 . 001 nuclear build full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 19.4 m -83.36 165.11 19.55 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.26 -0.9 . . . . 0.27 109.166 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 6.1 tt -59.1 -41.94 89.31 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.273 -0.892 . . . . 0.3 110.274 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -68.09 -39.22 82.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.071 -1.018 . . . . 0.52 110.178 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -58.01 -32.98 68.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.129 -0.982 . . . . 0.23 109.761 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 16' ' ' LEU . . . . . 0.418 ' HA ' HD23 ' E' ' 16' ' ' LEU . 85.5 mt -72.43 -29.23 63.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.938 . . . . 0.01 109.468 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -62.77 -31.43 72.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.309 -0.869 . . . . 0.26 109.949 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 48.4 m-20 -58.38 -28.78 65.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.203 -0.936 . . . . 0.42 109.48 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 19' ' ' TYR . . . . . 0.643 ' CG ' HD12 ' E' ' 2' ' ' ILE . 37.0 m-85 -96.83 13.89 27.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -0.931 . . . . 0.11 110.296 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 5.0 t -83.68 156.76 22.48 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.875 -1.141 . . . . 0.05 109.522 -179.593 -157.805 77.064 173.72 104.164 2.018 103.744 -89.885 -76.218 1 1 . 1 . 001 nuclear build full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 C--N 1.301 -1.506 0 CA-C-O 117.934 -1.031 . . . . 0.43 109.369 -179.91 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' F' F ' 1' ' ' PHE . . . . . 0.545 ' O ' HG22 ' F' ' 2' ' ' VAL . 20.8 t80 . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.308 -0.627 . . . . 0.42 109.308 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 2' ' ' VAL . . . . . 0.545 HG22 ' O ' ' F' ' 1' ' ' PHE . 7.9 m 43.1 -158.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.748 -0.595 . . . . 0.13 111.38 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 3' ' ' ASN . . . . . 0.478 ' H ' HD11 ' A' ' 10' ' ' ILE . 2.2 t-20 -153.43 -172.0 4.09 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.25 -0.906 . . . . 0.27 109.572 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 4' ' ' GLN . . . . . 0.693 ' HG3' HG11 ' E' ' 3' ' ' VAL . 10.9 tt0 -53.03 -34.67 57.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.594 -0.691 . . . . 0.19 109.426 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -53.0 -21.68 4.74 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.438 -0.789 . . . . 0.14 110.533 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 6' ' ' LEU . . . . . 0.897 HD21 ' H4 ' ' A' ' 22' ' ' IPH . 26.5 mt -118.56 -28.96 5.55 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.098 -1.001 . . . . 0.06 109.939 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 7' ' ' CYS . . . . . 0.406 ' HB3' ' HA ' ' F' ' 4' ' ' GLN . 35.1 t -66.71 -45.75 77.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.325 -0.859 . . . . 0.04 109.654 -179.76 173.73 -172.379 132.048 102.944 2.024 104.804 81.733 -174.647 2 2 . 1 . 001 nuclear build full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.7 -31.09 74.12 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.594 -1.003 . . . . 0.0 110.594 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 22.3 p -56.22 -24.6 43.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.088 -1.242 . . . . 0.01 109.948 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -103.34 -18.56 14.8 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.184 -0.947 . . . . 0.11 110.893 -178.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 11' ' ' LEU . . . . . 0.651 HD23 ' H5 ' ' E' ' 22' ' ' IPH . 56.3 mt -69.89 -34.61 73.77 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.541 -1.281 . . . . 0.01 107.541 178.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 12' ' ' VAL . . . . . 0.595 HG21 HG21 ' H' ' 12' ' ' VAL . 28.6 m -64.95 -36.7 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.79 -0.569 . . . . 0.0 110.224 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 13' ' ' GLU . . . . . 0.412 ' N ' HG23 ' F' ' 12' ' ' VAL . 25.6 mt-10 -54.82 -49.39 71.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.065 -1.022 . . . . 0.09 109.752 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 14' ' ' ALA . . . . . 0.486 ' O ' HG23 ' F' ' 18' ' ' VAL . . . -73.09 -28.1 62.09 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.273 -0.892 . . . . 0.01 109.403 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 15' ' ' LEU . . . . . 0.423 ' HB2' ' HA ' ' F' ' 12' ' ' VAL . 9.2 mt -59.52 -64.23 1.02 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.342 -0.849 . . . . 0.01 110.33 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 16' ' ' TYR . . . . . 0.503 ' HB3' ' CE1' ' F' ' 24' ' ' PHE . 1.7 p90 -71.07 -11.96 61.25 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.851 -178.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 17' ' ' LEU . . . . . 0.549 HD11 ' H3 ' ' K' ' 22' ' ' IPH . 3.1 tt -74.17 -36.2 64.07 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 106.689 -1.597 . . . . 0.1 106.689 176.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 18' ' ' VAL . . . . . 0.486 HG23 ' O ' ' F' ' 14' ' ' ALA . 99.5 t -76.51 -35.44 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.486 -0.931 . . . . 0.14 108.486 178.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 19' ' ' CYS . . . . . 0.425 ' HB2' ' HA ' ' F' ' 16' ' ' TYR . 51.7 m -74.03 -22.87 59.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.36 -0.838 . . . . 0.06 109.636 179.607 -76.218 -89.885 173.72 103.744 2.018 104.164 77.064 -157.805 2 2 . 1 . 001 nuclear build full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.13 -115.52 5.19 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.583 -1.407 . . . . 0.13 109.583 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -83.89 -21.9 31.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -1.138 . . . . 0.48 109.712 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 22' ' ' ARG . . . . . 0.406 ' HB2' ' HB3' ' F' ' 19' ' ' CYS . 31.8 mtm180 -59.16 177.14 0.18 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.168 -0.958 . . . . 0.29 109.394 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 23' ' ' GLY . . . . . 0.416 ' HA3' ' HA ' ' H' ' 27' ' ' THR . . . -125.4 -176.42 14.53 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.308 -1.517 . . . . 0.01 109.308 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 24' ' ' PHE . . . . . 0.503 ' CE1' ' HB3' ' F' ' 16' ' ' TYR . 3.9 p90 -158.63 163.32 37.03 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.13 -1.217 . . . . 0.0 109.876 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -108.96 122.93 48.28 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.26 -0.9 . . . . 0.32 108.693 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -109.32 115.65 30.38 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.432 -0.792 . . . . 0.0 109.921 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 27' ' ' THR . . . . . 0.413 ' HA ' ' HA3' ' H' ' 23' ' ' GLY . 37.4 p -125.22 98.64 35.24 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.096 -1.002 . . . . 0.23 109.597 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 28' ' ' PRO . . . . . 0.528 ' HA ' HG21 ' E' ' 3' ' ' VAL . 36.7 Cg_endo -79.26 59.34 7.36 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 121.394 1.396 . . . . 0.04 109.752 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -159.84 75.31 0.62 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.283 -0.885 . . . . 0.4 109.458 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.967 -1.016 . . . . 0.62 109.243 179.882 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.432 -1.467 . . . . 0.29 109.432 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' G' G ' 2' ' ' ILE . . . . . 0.634 HD12 ' CG ' ' G' ' 19' ' ' TYR . 10.3 tt -130.29 -42.46 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.251 -1.146 . . . . 0.05 109.201 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 3' ' ' VAL . . . . . 0.708 HG11 ' HG3' ' H' ' 4' ' ' GLN . 2.8 t -66.08 -61.73 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 121.321 -0.862 . . . . 0.01 109.283 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.08 -17.73 28.68 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.299 -0.876 . . . . 0.46 110.301 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -87.04 -35.16 18.91 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.844 -1.16 . . . . 0.25 110.417 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 58.6 m -103.75 -23.49 13.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.992 -1.067 . . . . 0.0 110.969 -178.594 -54.875 -42.765 -97.092 104.532 2.022 104.065 129.374 -72.647 1 1 . 1 . 001 nuclear build full ' G' G ' 7' ' ' CYS . . . . . 0.412 ' HB2' HD11 ' H' ' 11' ' ' LEU . 48.4 t -76.58 -1.95 30.05 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.311 -0.956 . . . . 0.06 110.364 179.461 -174.504 81.704 131.985 105.072 2.022 102.829 -172.522 173.692 2 2 . 1 . 001 nuclear build full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 16.2 p -86.68 -50.55 6.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.452 -1.405 . . . . 0.24 109.34 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 16.4 m -154.91 37.12 0.4 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.92 . . . . 0.28 109.608 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 10' ' ' ILE . . . . . 0.635 HG23 ' C2 ' ' G' ' 22' ' ' IPH . 3.6 mp 63.99 139.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 122.005 0.907 . . . . 0.1 110.513 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 66.2 m -95.6 174.24 7.09 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.966 -0.753 . . . . 0.05 108.966 179.419 -72.647 129.374 -97.092 104.065 2.022 104.532 -42.765 -54.875 1 1 . 1 . 001 nuclear build full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 19.3 m -83.54 165.2 19.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.239 -0.913 . . . . 0.28 109.111 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 6.1 tt -59.13 -41.83 89.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.273 -0.892 . . . . 0.3 110.373 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -68.31 -38.86 82.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.088 -1.008 . . . . 0.53 110.176 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -58.31 -33.08 69.09 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.133 -0.979 . . . . 0.23 109.785 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 85.1 mt -72.2 -29.5 64.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.15 -0.969 . . . . 0.01 109.506 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -62.67 -31.43 72.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.26 109.943 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -58.43 -28.58 65.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.4 109.42 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 19' ' ' TYR . . . . . 0.634 ' CG ' HD12 ' G' ' 2' ' ' ILE . 37.3 m-85 -96.82 13.39 28.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.151 -0.968 . . . . 0.11 110.348 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 5.0 t -83.34 157.0 22.74 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.774 -1.203 . . . . 0.05 109.587 -179.554 -157.761 76.762 173.745 104.191 2.019 103.928 -89.746 -76.385 1 1 . 1 . 001 nuclear build full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 C--N 1.303 -1.429 0 CA-C-O 118.034 -0.984 . . . . 0.41 109.547 -179.903 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' H' H ' 1' ' ' PHE . . . . . 0.546 ' O ' HG22 ' H' ' 2' ' ' VAL . 21.1 t80 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.328 -0.619 . . . . 0.42 109.328 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 2' ' ' VAL . . . . . 0.546 HG22 ' O ' ' H' ' 1' ' ' PHE . 8.2 m 43.09 -159.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.68 -0.637 . . . . 0.12 111.44 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 3' ' ' ASN . . . . . 0.424 ' H ' HD11 ' K' ' 10' ' ' ILE . 2.2 t-20 -152.67 -172.4 4.23 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.306 -0.871 . . . . 0.26 109.772 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 4' ' ' GLN . . . . . 0.708 ' HG3' HG11 ' G' ' 3' ' ' VAL . 11.0 tt0 -52.55 -34.73 51.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.46 -0.775 . . . . 0.19 109.494 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -52.96 -21.52 4.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.341 -0.849 . . . . 0.14 110.497 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 6' ' ' LEU . . . . . 0.83 HD21 ' H4 ' ' K' ' 22' ' ' IPH . 27.2 mt -118.78 -28.55 5.57 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.052 -1.03 . . . . 0.05 109.971 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 7' ' ' CYS . . . . . 0.412 ' HB3' ' HA ' ' H' ' 4' ' ' GLN . 35.0 t -66.95 -45.63 77.19 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.243 -0.911 . . . . 0.04 109.66 -179.73 173.692 -172.522 131.985 102.829 2.022 105.072 81.704 -174.504 2 2 . 1 . 001 nuclear build full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.7 -31.46 75.43 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 21.5 p -55.82 -24.37 35.83 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.935 -1.332 . . . . 0.01 109.908 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 10' ' ' HIS . . . . . 0.405 ' HA ' ' HG3' ' H' ' 13' ' ' GLU . 99.1 m-70 -103.61 -18.98 14.52 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.085 -1.009 . . . . 0.11 110.889 -178.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 11' ' ' LEU . . . . . 0.651 HD23 ' H5 ' ' G' ' 22' ' ' IPH . 55.9 mt -69.6 -34.84 74.69 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.409 -1.33 . . . . 0.01 107.409 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 12' ' ' VAL . . . . . 0.595 HG21 HG21 ' F' ' 12' ' ' VAL . 27.8 m -64.77 -37.11 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.873 -0.517 . . . . 0.0 110.128 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 13' ' ' GLU . . . . . 0.407 ' N ' HG23 ' H' ' 12' ' ' VAL . 25.7 mt-10 -54.58 -49.3 70.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.084 -1.01 . . . . 0.09 109.875 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 14' ' ' ALA . . . . . 0.463 ' O ' HG23 ' H' ' 18' ' ' VAL . . . -73.0 -28.72 62.53 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.259 -0.9 . . . . 0.01 109.404 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 15' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' H' ' 12' ' ' VAL . 9.2 mt -58.8 -64.74 0.83 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.286 -0.884 . . . . 0.0 110.282 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 16' ' ' TYR . . . . . 0.499 ' HB3' ' CE1' ' H' ' 24' ' ' PHE . 1.7 p90 -70.61 -12.6 61.66 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.143 -1.023 . . . . 0.0 110.865 -178.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 17' ' ' LEU . . . . . 0.614 HD11 ' H3 ' ' A' ' 22' ' ' IPH . 3.3 tt -73.56 -36.0 65.55 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 106.745 -1.576 . . . . 0.1 106.745 176.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 18' ' ' VAL . . . . . 0.463 HG23 ' O ' ' H' ' 14' ' ' ALA . 99.5 t -76.85 -35.31 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 108.539 -0.912 . . . . 0.14 108.539 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 19' ' ' CYS . . . . . 0.416 ' HB2' ' HA ' ' H' ' 16' ' ' TYR . 50.9 m -74.02 -22.85 59.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.262 -0.899 . . . . 0.06 109.481 179.547 -76.385 -89.746 173.745 103.928 2.019 104.191 76.762 -157.761 2 2 . 1 . 001 nuclear build full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.31 -115.57 5.16 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.561 -1.416 . . . . 0.13 109.561 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -83.92 -21.67 31.8 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.309 -1.113 . . . . 0.48 109.807 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 22' ' ' ARG . . . . . 0.405 ' HB2' ' HB3' ' H' ' 19' ' ' CYS . 31.7 mtm180 -59.34 177.33 0.19 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.125 -0.984 . . . . 0.29 109.562 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 23' ' ' GLY . . . . . 0.426 ' HA2' ' HD2' ' F' ' 28' ' ' PRO . . . -125.54 -176.85 14.67 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.581 -1.408 . . . . 0.01 109.581 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 24' ' ' PHE . . . . . 0.499 ' CE1' ' HB3' ' H' ' 16' ' ' TYR . 3.9 p90 -158.43 163.39 37.25 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.2 -1.177 . . . . 0.0 109.786 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -109.14 123.06 48.6 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.246 -0.908 . . . . 0.34 108.702 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -109.55 115.66 30.33 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.366 -0.834 . . . . 0.0 109.834 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 27' ' ' THR . . . . . 0.416 ' HA ' ' HA3' ' F' ' 23' ' ' GLY . 36.4 p -125.3 98.39 35.5 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.159 -0.963 . . . . 0.24 109.442 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 28' ' ' PRO . . . . . 0.527 ' HA ' HG21 ' G' ' 3' ' ' VAL . 36.4 Cg_endo -79.05 59.88 7.56 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 121.333 1.355 . . . . 0.04 109.835 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -160.31 75.3 0.58 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.375 -0.828 . . . . 0.41 109.431 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.949 -1.024 . . . . 0.62 109.369 179.88 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 N-CA-C 109.532 -1.427 . . . . 0.29 109.532 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' I' I ' 2' ' ' ILE . . . . . 0.656 HD12 ' CG ' ' I' ' 19' ' ' TYR . 10.4 tt -130.41 -42.33 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.192 -1.181 . . . . 0.05 109.278 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 3' ' ' VAL . . . . . 0.708 HG11 ' HG3' ' J' ' 4' ' ' GLN . 2.8 t -66.0 -61.96 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 121.396 -0.815 . . . . 0.01 109.243 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 4' ' ' GLU . . . . . 0.413 ' O ' HG23 ' I' ' 8' ' ' THR . 0.8 OUTLIER -58.73 -18.0 27.76 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.36 -0.838 . . . . 0.46 110.297 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -86.81 -35.47 19.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.874 -1.141 . . . . 0.24 110.498 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 58.6 m -103.53 -23.49 13.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.896 -1.127 . . . . 0.01 110.959 -178.66 -54.866 -42.485 -97.48 104.518 2.023 104.012 129.157 -72.254 1 1 . 1 . 001 nuclear build full ' I' I ' 7' ' ' CYS . . . . . 0.418 ' HB2' HD11 ' J' ' 11' ' ' LEU . 48.2 t -76.65 -1.54 28.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.182 -0.949 . . . . 0.07 110.287 179.347 -174.534 81.725 132.409 104.818 2.022 102.974 -172.396 173.499 2 2 . 1 . 001 nuclear build full ' I' I ' 8' ' ' THR . . . . . 0.413 HG23 ' O ' ' I' ' 4' ' ' GLU . 16.0 p -86.98 -50.73 6.46 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.5 -1.375 . . . . 0.25 109.273 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 16.3 m -154.91 37.1 0.4 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.176 -0.952 . . . . 0.29 109.653 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 10' ' ' ILE . . . . . 0.643 HG23 ' C2 ' ' I' ' 22' ' ' IPH . 3.5 mp 64.13 139.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 122.001 0.905 . . . . 0.1 110.615 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 67.6 m -95.27 174.21 7.16 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.986 -0.746 . . . . 0.05 108.986 179.459 -72.254 129.157 -97.48 104.012 2.023 104.518 -42.485 -54.866 1 1 . 1 . 001 nuclear build full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 18.6 m -83.47 164.65 19.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -0.923 . . . . 0.27 109.165 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 6.0 tt -58.7 -41.57 86.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.377 -0.827 . . . . 0.3 110.337 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -68.68 -38.85 80.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.085 -1.01 . . . . 0.51 110.136 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -58.29 -33.26 69.25 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.243 -0.911 . . . . 0.22 109.745 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 87.7 mt -72.05 -29.48 64.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.162 -0.961 . . . . 0.01 109.421 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -62.67 -31.14 71.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.333 -0.854 . . . . 0.27 109.914 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -58.72 -28.85 66.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.193 -0.942 . . . . 0.42 109.412 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 19' ' ' TYR . . . . . 0.656 ' CG ' HD12 ' I' ' 2' ' ' ILE . 37.0 m-85 -96.48 13.41 28.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 0.11 110.388 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 4.9 t -83.3 156.6 22.99 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.769 -1.207 . . . . 0.05 109.622 -179.598 -157.649 77.17 173.7 104.136 2.018 103.758 -90.056 -76.247 1 1 . 1 . 001 nuclear build full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 t30 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.02 -0.99 . . . . 0.41 109.501 -179.977 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' J' J ' 1' ' ' PHE . . . . . 0.55 ' O ' HG22 ' J' ' 2' ' ' VAL . 20.8 t80 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.328 -0.619 . . . . 0.42 109.328 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 2' ' ' VAL . . . . . 0.55 HG22 ' O ' ' J' ' 1' ' ' PHE . 7.3 m 43.31 -159.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 121.764 -0.585 . . . . 0.13 111.422 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 3' ' ' ASN . . . . . 0.482 ' H ' HD11 ' E' ' 10' ' ' ILE . 2.2 t-20 -152.65 -172.09 4.13 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.363 -0.836 . . . . 0.27 109.791 -178.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 4' ' ' GLN . . . . . 0.708 ' HG3' HG11 ' I' ' 3' ' ' VAL . 10.9 tt0 -52.96 -34.41 55.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.504 -0.747 . . . . 0.2 109.422 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 5' ' ' HIS . . . . . 0.412 ' CD2' HG21 ' E' ' 10' ' ' ILE . 42.6 t60 -53.24 -21.27 5.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.408 -0.807 . . . . 0.14 110.516 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 6' ' ' LEU . . . . . 0.862 HD21 ' H4 ' ' E' ' 22' ' ' IPH . 26.7 mt -119.09 -29.05 5.35 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.225 -0.922 . . . . 0.06 109.92 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 7' ' ' CYS . . . . . 0.411 ' HB3' ' HA ' ' J' ' 4' ' ' GLN . 34.5 t -66.41 -45.53 79.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.04 109.728 -179.758 173.499 -172.396 132.409 102.974 2.022 104.818 81.725 -174.534 2 2 . 1 . 001 nuclear build full ' J' J ' 8' ' ' GLY . . . . . 0.401 ' HA3' ' OH ' ' J' ' 26' ' ' TYR . . . -60.89 -31.58 76.61 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 23.9 p -55.68 -24.27 33.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.946 -1.326 . . . . 0.01 110.016 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 10' ' ' HIS . . . . . 0.412 ' HA ' ' HG3' ' J' ' 13' ' ' GLU . 99.0 m-70 -103.89 -18.49 14.6 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.211 -0.931 . . . . 0.11 110.899 -178.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 11' ' ' LEU . . . . . 0.636 HD23 ' H5 ' ' I' ' 22' ' ' IPH . 56.7 mt -70.05 -34.3 73.05 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.419 -1.326 . . . . 0.01 107.419 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 12' ' ' VAL . . . . . 0.615 HG21 HG21 ' L' ' 12' ' ' VAL . 27.8 m -65.22 -37.05 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.783 -0.573 . . . . 0.0 110.05 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 13' ' ' GLU . . . . . 0.412 ' HG3' ' HA ' ' J' ' 10' ' ' HIS . 26.1 mt-10 -54.64 -48.77 71.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.04 -1.037 . . . . 0.1 109.836 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 14' ' ' ALA . . . . . 0.473 ' O ' HG23 ' J' ' 18' ' ' VAL . . . -73.63 -28.47 61.81 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.224 -0.922 . . . . 0.01 109.288 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 15' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' J' ' 12' ' ' VAL . 9.3 mt -58.94 -64.33 0.98 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.361 -0.837 . . . . 0.0 110.326 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 16' ' ' TYR . . . . . 0.498 ' HB3' ' CE1' ' J' ' 24' ' ' PHE . 1.8 p90 -71.04 -12.52 61.57 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.129 -1.029 . . . . 0.0 110.838 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 17' ' ' LEU . . . . . 0.608 HD11 ' H3 ' ' C' ' 22' ' ' IPH . 3.2 tt -73.89 -35.39 64.67 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 106.822 -1.547 . . . . 0.1 106.822 176.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 18' ' ' VAL . . . . . 0.473 HG23 ' O ' ' J' ' 14' ' ' ALA . 96.6 t -77.25 -35.66 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 108.279 -1.008 . . . . 0.13 108.279 178.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 19' ' ' CYS . . . . . 0.422 ' HB2' ' HA ' ' J' ' 16' ' ' TYR . 51.6 m -73.87 -22.7 59.64 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.372 -0.83 . . . . 0.06 109.509 179.614 -76.247 -90.056 173.7 103.758 2.018 104.136 77.17 -157.649 2 2 . 1 . 001 nuclear build full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.15 -115.44 5.15 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.593 -1.403 . . . . 0.13 109.593 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -84.0 -21.93 31.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.211 -1.17 . . . . 0.48 109.716 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 22' ' ' ARG . . . . . 0.413 ' HB2' ' HB3' ' J' ' 19' ' ' CYS . 31.5 mtm180 -59.07 177.46 0.16 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.071 -1.018 . . . . 0.29 109.526 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 23' ' ' GLY . . . . . 0.425 ' HA2' ' HD2' ' L' ' 28' ' ' PRO . . . -125.5 -176.16 14.44 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.459 -1.457 . . . . 0.01 109.459 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 24' ' ' PHE . . . . . 0.498 ' CE1' ' HB3' ' J' ' 16' ' ' TYR . 3.9 p90 -158.98 163.15 36.71 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.257 -1.143 . . . . 0.0 109.851 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -108.94 123.03 48.46 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.292 -0.88 . . . . 0.33 108.673 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 26' ' ' TYR . . . . . 0.401 ' OH ' ' HA3' ' J' ' 8' ' ' GLY . 52.8 t80 -109.47 115.54 30.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.444 -0.785 . . . . 0.0 109.866 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 27' ' ' THR . . . . . 0.434 ' HA ' ' HA3' ' L' ' 23' ' ' GLY . 36.2 p -125.24 98.55 35.35 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.157 -0.965 . . . . 0.24 109.459 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 28' ' ' PRO . . . . . 0.533 ' HA ' HG21 ' I' ' 3' ' ' VAL . 36.5 Cg_endo -79.05 59.68 7.49 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 121.282 1.321 . . . . 0.05 109.963 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -160.18 75.31 0.59 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.365 -0.834 . . . . 0.4 109.476 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 6.3 m . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.011 -0.995 . . . . 0.62 109.409 179.935 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.409 -1.476 . . . . 0.29 109.409 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' K' K ' 2' ' ' ILE . . . . . 0.654 HD12 ' CG ' ' K' ' 19' ' ' TYR . 10.3 tt -130.38 -42.47 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -1.195 . . . . 0.05 109.189 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 3' ' ' VAL . . . . . 0.713 HG11 ' HG3' ' L' ' 4' ' ' GLN . 2.8 t -65.96 -61.88 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.371 -0.831 . . . . 0.01 109.271 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 4' ' ' GLU . . . . . 0.403 ' O ' HG23 ' K' ' 8' ' ' THR . 0.8 OUTLIER -59.09 -17.53 27.01 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.224 -0.923 . . . . 0.46 110.333 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -87.09 -35.39 18.72 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.883 -1.135 . . . . 0.24 110.495 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 58.4 m -103.68 -23.47 13.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.051 -1.03 . . . . 0.01 110.985 -178.653 -54.783 -42.815 -97.028 104.561 2.021 104.04 129.17 -72.535 1 1 . 1 . 001 nuclear build full ' K' K ' 7' ' ' CYS . . . . . 0.419 ' HB2' HD11 ' L' ' 11' ' ' LEU . 48.5 t -76.7 -1.57 28.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.102 -0.999 . . . . 0.06 110.289 179.359 -174.463 81.965 131.997 105.042 2.022 102.882 -172.541 173.841 2 2 . 1 . 001 nuclear build full ' K' K ' 8' ' ' THR . . . . . 0.403 HG23 ' O ' ' K' ' 4' ' ' GLU . 15.7 p -86.68 -50.57 6.69 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.435 -1.416 . . . . 0.25 109.216 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 9' ' ' SER . . . . . 0.402 ' O ' ' HB ' ' K' ' 10' ' ' ILE . 16.4 m -155.04 36.63 0.39 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.197 -0.94 . . . . 0.3 109.682 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 10' ' ' ILE . . . . . 0.651 HG23 ' C2 ' ' K' ' 22' ' ' IPH . 3.6 mp 64.57 138.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 122.069 0.937 . . . . 0.11 110.743 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 66.7 m -94.86 174.46 7.09 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.001 -0.741 . . . . 0.05 109.001 179.407 -72.535 129.17 -97.028 104.04 2.021 104.561 -42.815 -54.783 1 1 . 1 . 001 nuclear build full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 19.0 m -83.52 165.08 19.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.191 -0.943 . . . . 0.27 109.102 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 6.2 tt -58.99 -41.92 88.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.3 110.315 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -68.23 -39.45 82.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.005 -1.06 . . . . 0.51 110.077 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -57.78 -33.25 68.34 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.129 -0.982 . . . . 0.22 109.753 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 16' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' K' ' 16' ' ' LEU . 86.0 mt -72.1 -29.62 64.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.185 -0.947 . . . . 0.01 109.477 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -62.54 -31.28 72.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.26 109.9 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -58.71 -28.37 65.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.159 -0.963 . . . . 0.42 109.445 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 19' ' ' TYR . . . . . 0.654 ' CG ' HD12 ' K' ' 2' ' ' ILE . 36.7 m-85 -96.9 13.62 28.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.938 . . . . 0.11 110.296 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 4.9 t -83.44 156.88 22.69 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.755 -1.216 . . . . 0.05 109.631 -179.553 -157.625 77.204 174.002 104.158 2.019 103.818 -90.005 -76.264 1 1 . 1 . 001 nuclear build full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 C--N 1.302 -1.467 0 CA-C-O 117.947 -1.025 . . . . 0.41 109.403 -179.881 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' L' L ' 1' ' ' PHE . . . . . 0.546 ' O ' HG22 ' L' ' 2' ' ' VAL . 21.2 t80 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.383 -0.599 . . . . 0.42 109.383 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 2' ' ' VAL . . . . . 0.546 HG22 ' O ' ' L' ' 1' ' ' PHE . 7.5 m 43.04 -158.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 CA-C-O 121.352 0.596 . . . . 0.12 111.408 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 3' ' ' ASN . . . . . 0.433 ' H ' HD11 ' C' ' 10' ' ' ILE . 2.2 t-20 -153.25 -172.19 4.16 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.248 -0.908 . . . . 0.26 109.664 -178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 4' ' ' GLN . . . . . 0.713 ' HG3' HG11 ' K' ' 3' ' ' VAL . 10.8 tt0 -52.79 -34.87 55.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.53 -0.731 . . . . 0.2 109.448 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 5' ' ' HIS . . . . . 0.414 ' CD2' HG21 ' C' ' 10' ' ' ILE . 43.2 t60 -52.84 -21.75 4.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.405 -0.81 . . . . 0.14 110.556 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 6' ' ' LEU . . . . . 0.841 HD21 ' H4 ' ' C' ' 22' ' ' IPH . 25.7 mt -118.51 -29.02 5.56 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.061 -1.024 . . . . 0.06 109.836 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 7' ' ' CYS . . . . . 0.417 ' HB3' ' HA ' ' L' ' 4' ' ' GLN . 35.4 t -66.54 -45.49 79.26 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.305 -0.872 . . . . 0.04 109.752 -179.701 173.841 -172.541 131.997 102.882 2.022 105.042 81.965 -174.463 2 2 . 1 . 001 nuclear build full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.03 -31.12 75.44 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 23.3 p -56.05 -24.41 39.46 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.07 -1.253 . . . . 0.01 109.965 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 10' ' ' HIS . . . . . 0.419 ' HA ' ' HG3' ' L' ' 13' ' ' GLU . 99.2 m-70 -103.51 -18.62 14.7 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.064 -1.022 . . . . 0.11 110.832 -178.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 11' ' ' LEU . . . . . 0.636 HD23 ' H5 ' ' K' ' 22' ' ' IPH . 55.7 mt -69.78 -34.17 73.38 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.414 -1.328 . . . . 0.01 107.414 178.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 12' ' ' VAL . . . . . 0.615 HG21 HG21 ' J' ' 12' ' ' VAL . 27.5 m -65.66 -36.62 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.715 -0.616 . . . . 0.0 110.134 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 13' ' ' GLU . . . . . 0.419 ' HG3' ' HA ' ' L' ' 10' ' ' HIS . 25.3 mt-10 -54.68 -49.69 70.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.144 -0.972 . . . . 0.09 109.774 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 14' ' ' ALA . . . . . 0.477 ' O ' HG23 ' L' ' 18' ' ' VAL . . . -72.72 -28.87 62.92 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.32 -0.863 . . . . 0.01 109.235 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 15' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' L' ' 12' ' ' VAL . 9.1 mt -58.87 -64.17 1.03 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.361 -0.837 . . . . 0.0 110.257 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 16' ' ' TYR . . . . . 0.501 ' HB3' ' CE1' ' L' ' 24' ' ' PHE . 1.7 p90 -71.18 -12.12 61.31 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.911 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 17' ' ' LEU . . . . . 0.584 HD11 ' H3 ' ' E' ' 22' ' ' IPH . 3.2 tt -74.04 -35.83 64.35 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 106.763 -1.569 . . . . 0.1 106.763 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 18' ' ' VAL . . . . . 0.477 HG23 ' O ' ' L' ' 14' ' ' ALA . 98.3 t -76.85 -35.31 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.391 -0.966 . . . . 0.13 108.391 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 19' ' ' CYS . . . . . 0.421 ' HB2' ' HA ' ' L' ' 16' ' ' TYR . 51.5 m -74.32 -22.39 59.28 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.385 -0.822 . . . . 0.06 109.556 179.636 -76.264 -90.005 174.002 103.818 2.019 104.158 77.204 -157.625 2 2 . 1 . 001 nuclear build full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.84 -115.37 5.21 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.636 -1.386 . . . . 0.13 109.636 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -84.0 -22.13 31.45 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.244 -1.151 . . . . 0.49 109.744 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 22' ' ' ARG . . . . . 0.405 ' HB2' ' HB3' ' L' ' 19' ' ' CYS . 32.2 mtm180 -59.07 177.58 0.16 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.3 109.54 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 23' ' ' GLY . . . . . 0.434 ' HA3' ' HA ' ' J' ' 27' ' ' THR . . . -125.75 -176.52 14.55 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.464 -1.455 . . . . 0.01 109.464 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 24' ' ' PHE . . . . . 0.501 ' CE1' ' HB3' ' L' ' 16' ' ' TYR . 3.7 p90 -158.67 163.6 36.72 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.081 -1.247 . . . . 0.0 109.859 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -109.29 122.67 47.85 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.278 -0.889 . . . . 0.33 108.733 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -109.08 115.73 30.6 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.414 -0.804 . . . . 0.0 109.84 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 27' ' ' THR . . . . . 0.423 ' HA ' ' HA3' ' J' ' 23' ' ' GLY . 36.4 p -125.3 98.57 35.16 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.088 -1.007 . . . . 0.23 109.45 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 28' ' ' PRO . . . . . 0.524 ' HA ' HG21 ' K' ' 3' ' ' VAL . 36.6 Cg_endo -79.0 59.54 7.42 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 121.355 1.37 . . . . 0.04 109.865 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -160.06 75.48 0.6 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.389 -0.819 . . . . 0.4 109.502 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.903 -1.046 . . . . 0.62 109.469 179.899 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 22' ' ' IPH . . . . . 0.897 ' H4 ' HD21 ' F' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 22' ' ' IPH . . . . . 0.841 ' H4 ' HD21 ' L' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 22' ' ' IPH . . . . . 0.862 ' H4 ' HD21 ' J' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 22' ' ' IPH . . . . . 0.858 ' H4 ' HD21 ' D' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 22' ' ' IPH . . . . . 0.849 ' H4 ' HD21 ' B' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 22' ' ' IPH . . . . . 0.83 ' H4 ' HD21 ' H' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.489 -1.444 . . . . 0.29 109.489 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.652 HD12 ' CG ' ' A' ' 19' ' ' TYR . 10.5 tt -130.31 -42.64 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.256 -1.143 . . . . 0.05 109.29 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.705 HG11 ' HG3' ' B' ' 4' ' ' GLN . 2.8 t -65.77 -62.01 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.314 -0.866 . . . . 0.01 109.249 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.403 ' O ' HG23 ' A' ' 8' ' ' THR . 0.8 OUTLIER -58.78 -18.01 28.29 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.397 -0.814 . . . . 0.46 110.24 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -86.76 -35.15 19.35 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.942 -1.099 . . . . 0.24 110.537 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.7 m -103.91 -23.77 13.33 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.976 -1.078 . . . . 0.0 111.015 -178.492 -54.903 -42.76 -97.206 104.568 2.023 104.076 129.264 -72.529 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.413 ' HB2' HD11 ' B' ' 11' ' ' LEU . 48.0 t -76.29 -2.39 31.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.204 -0.935 . . . . 0.07 110.264 179.338 -174.583 82.104 131.925 104.871 2.022 103.039 -172.64 173.661 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 4' ' ' GLU . 15.7 p -86.15 -50.33 7.08 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.473 -1.392 . . . . 0.25 109.305 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.401 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 16.2 m -155.24 36.99 0.39 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.275 -0.891 . . . . 0.29 109.777 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.641 HG23 ' C2 ' ' A' ' 22' ' ' IPH . 3.6 mp 64.22 138.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 122.003 0.906 . . . . 0.1 110.701 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 66.7 m -95.05 174.41 7.09 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.031 -0.729 . . . . 0.05 109.031 179.466 -72.529 129.264 -97.206 104.076 2.023 104.568 -42.76 -54.903 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.1 m -83.61 164.27 19.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.895 . . . . 0.27 109.285 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.1 tt -58.35 -41.67 85.21 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.329 -0.857 . . . . 0.3 110.403 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -68.44 -38.99 81.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.026 -1.046 . . . . 0.52 110.186 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -58.38 -33.1 69.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.165 -0.959 . . . . 0.23 109.666 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.43 ' HA ' HD23 ' A' ' 16' ' ' LEU . 85.1 mt -72.03 -29.53 64.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.228 -0.92 . . . . 0.01 109.487 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -62.76 -31.11 72.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.863 . . . . 0.26 109.922 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 -58.74 -28.34 65.79 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.088 -1.007 . . . . 0.42 109.454 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.652 ' CG ' HD12 ' A' ' 2' ' ' ILE . 36.7 m-85 -96.92 13.18 29.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.11 110.402 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.0 t -83.06 157.04 23.03 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.836 -1.165 . . . . 0.05 109.593 -179.497 -157.737 76.709 173.549 104.235 2.019 103.93 -89.424 -76.609 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 C--N 1.302 -1.494 0 CA-C-O 117.915 -1.041 . . . . 0.41 109.554 -179.861 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.547 ' O ' HG22 ' B' ' 2' ' ' VAL . 20.8 t80 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.391 -0.596 . . . . 0.42 109.391 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' VAL . . . . . 0.547 HG22 ' O ' ' B' ' 1' ' ' PHE . 7.2 m 43.16 -159.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-O 121.312 0.577 . . . . 0.13 111.533 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . 0.473 ' H ' HD11 ' I' ' 10' ' ' ILE . 2.2 t-20 -152.84 -171.96 4.09 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.342 -0.849 . . . . 0.27 109.589 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.705 ' HG3' HG11 ' A' ' 3' ' ' VAL . 11.0 tt0 -53.0 -34.98 58.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.473 -0.767 . . . . 0.2 109.378 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' HIS . . . . . 0.415 ' CD2' HG21 ' I' ' 10' ' ' ILE . 41.9 t60 -52.42 -22.17 4.43 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.409 -0.807 . . . . 0.14 110.486 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.849 HD21 ' H4 ' ' I' ' 22' ' ' IPH . 27.3 mt -118.27 -29.07 5.63 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.99 -1.069 . . . . 0.06 109.9 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . 0.406 ' HB3' ' HA ' ' B' ' 4' ' ' GLN . 34.9 t -66.42 -45.5 79.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.29 -0.881 . . . . 0.04 109.752 -179.729 173.661 -172.64 131.925 103.039 2.022 104.871 82.104 -174.583 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . 0.402 ' HA3' ' OH ' ' B' ' 26' ' ' TYR . . . -60.8 -31.41 75.62 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 24.3 p -56.05 -24.01 36.95 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.139 -1.212 . . . . 0.01 110.086 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' HIS . . . . . 0.413 ' HA ' ' HG3' ' B' ' 13' ' ' GLU . 99.3 m-70 -103.89 -18.62 14.55 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.177 -0.952 . . . . 0.11 110.832 -178.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.636 HD23 ' H5 ' ' A' ' 22' ' ' IPH . 56.7 mt -69.99 -34.28 73.14 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.382 -1.34 . . . . 0.01 107.382 178.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.583 HG21 ' CG2' ' D' ' 12' ' ' VAL . 28.2 m -65.22 -36.56 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-O 121.167 0.508 . . . . 0.0 110.046 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.413 ' HG3' ' HA ' ' B' ' 10' ' ' HIS . 26.2 mt-10 -54.91 -49.42 71.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.098 -1.001 . . . . 0.09 109.846 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.489 ' O ' HG23 ' B' ' 18' ' ' VAL . . . -72.97 -28.42 62.39 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.305 -0.872 . . . . 0.01 109.357 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.402 ' HB2' ' HA ' ' B' ' 12' ' ' VAL . 9.2 mt -59.37 -64.31 0.99 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.371 -0.83 . . . . 0.0 110.205 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.501 ' HB3' ' CE1' ' B' ' 24' ' ' PHE . 1.7 p90 -71.17 -12.2 61.35 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.131 -1.028 . . . . 0.0 110.836 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.616 HD11 ' H3 ' ' G' ' 22' ' ' IPH . 3.1 tt -74.02 -35.56 64.37 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 106.802 -1.555 . . . . 0.1 106.802 176.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.489 HG23 ' O ' ' B' ' 14' ' ' ALA . 97.7 t -77.26 -35.16 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.457 -0.942 . . . . 0.14 108.457 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . 0.41 ' HB2' ' HA ' ' B' ' 16' ' ' TYR . 48.8 m -74.15 -23.1 59.21 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.375 -0.828 . . . . 0.06 109.485 179.598 -76.609 -89.424 173.549 103.93 2.019 104.235 76.709 -157.737 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.86 -116.18 5.24 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.478 -1.449 . . . . 0.13 109.478 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -83.64 -21.7 32.4 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.396 -1.061 . . . . 0.48 109.711 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 31.9 mtm180 -59.39 177.43 0.19 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.071 -1.018 . . . . 0.29 109.49 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' D' ' 27' ' ' THR . . . -125.5 -176.33 14.5 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.479 -1.448 . . . . 0.01 109.479 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.501 ' CE1' ' HB3' ' B' ' 16' ' ' TYR . 3.8 p90 -158.74 163.43 36.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.145 -1.209 . . . . 0.0 109.794 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -109.25 122.73 47.95 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.206 -0.934 . . . . 0.33 108.805 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.402 ' OH ' ' HA3' ' B' ' 8' ' ' GLY . 52.8 t80 -109.18 115.83 30.77 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.223 -0.923 . . . . 0.0 109.975 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.421 ' HA ' ' HA3' ' D' ' 23' ' ' GLY . 36.7 p -125.27 98.34 35.66 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.182 -0.948 . . . . 0.23 109.467 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' PRO . . . . . 0.533 ' HA ' HG21 ' A' ' 3' ' ' VAL . 36.7 Cg_endo -78.94 59.46 7.37 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 121.324 1.35 . . . . 0.04 109.848 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -159.99 75.56 0.61 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.36 -0.838 . . . . 0.4 109.481 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 6.3 m . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.986 -1.007 . . . . 0.62 109.248 179.891 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.404 -1.478 . . . . 0.29 109.404 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' ILE . . . . . 0.645 HD12 ' CG ' ' C' ' 19' ' ' TYR . 10.5 tt -130.45 -42.58 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.124 -1.221 . . . . 0.05 109.228 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . 0.695 HG11 ' HG3' ' D' ' 4' ' ' GLN . 2.8 t -65.91 -61.85 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.398 -0.814 . . . . 0.01 109.26 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.96 -17.89 28.78 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.354 -0.841 . . . . 0.45 110.293 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -86.79 -35.11 19.32 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.895 -1.128 . . . . 0.24 110.554 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' CYS . . . . . . . . . . . . . 58.4 m -104.04 -23.39 13.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.871 -1.143 . . . . 0.01 110.958 -178.486 -54.797 -42.888 -97.212 104.447 2.022 104.032 129.237 -72.479 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' CYS . . . . . 0.426 ' HB2' HD11 ' D' ' 11' ' ' LEU . 48.0 t -76.63 -1.95 30.24 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.276 -0.969 . . . . 0.07 110.267 179.342 -174.575 81.663 132.111 105.015 2.022 102.921 -172.364 173.641 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' THR . . . . . . . . . . . . . 16.5 p -86.68 -50.47 6.77 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.305 -1.497 . . . . 0.25 109.356 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' SER . . . . . 0.404 ' O ' ' HB ' ' C' ' 10' ' ' ILE . 16.5 m -155.02 37.12 0.4 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.29 109.659 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . 0.636 HG23 ' C2 ' ' C' ' 22' ' ' IPH . 3.5 mp 63.99 139.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-O 122.062 0.934 . . . . 0.1 110.555 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' CYS . . . . . . . . . . . . . 66.9 m -95.7 174.15 7.12 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.96 -0.756 . . . . 0.05 108.96 179.439 -72.479 129.237 -97.212 104.032 2.022 104.447 -42.888 -54.797 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 19.0 m -83.34 164.54 19.95 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.331 -0.856 . . . . 0.27 109.243 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' LEU . . . . . . . . . . . . . 6.1 tt -58.67 -41.55 86.4 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.324 -0.86 . . . . 0.3 110.367 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -68.56 -38.94 81.18 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.061 -1.024 . . . . 0.51 110.162 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -58.37 -33.2 69.32 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.134 -0.979 . . . . 0.22 109.746 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' LEU . . . . . . . . . . . . . 84.8 mt -72.12 -29.49 64.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 0.01 109.428 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -62.69 -31.19 72.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.294 -0.879 . . . . 0.26 109.964 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 47.1 m-20 -58.59 -28.76 65.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -0.961 . . . . 0.42 109.481 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' TYR . . . . . 0.645 ' CG ' HD12 ' C' ' 2' ' ' ILE . 36.9 m-85 -96.59 13.28 28.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.11 110.399 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' CYS . . . . . . . . . . . . . 5.0 t -83.14 156.46 23.25 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.8 -1.188 . . . . 0.05 109.672 -179.629 -157.824 77.085 173.834 104.06 2.017 103.866 -89.899 -76.356 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 C--N 1.303 -1.447 0 CA-C-O 118.02 -0.991 . . . . 0.41 109.554 -179.926 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 1' ' ' PHE . . . . . 0.546 ' O ' HG22 ' D' ' 2' ' ' VAL . 20.8 t80 . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.323 -0.621 . . . . 0.42 109.323 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 2' ' ' VAL . . . . . 0.546 HG22 ' O ' ' D' ' 1' ' ' PHE . 7.8 m 43.2 -159.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.696 -0.628 . . . . 0.12 111.444 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 3' ' ' ASN . . . . . 0.437 ' H ' HD11 ' G' ' 10' ' ' ILE . 2.2 t-20 -152.58 -171.83 4.05 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.264 -0.898 . . . . 0.26 109.644 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . 0.695 ' HG3' HG11 ' C' ' 3' ' ' VAL . 10.8 tt0 -53.22 -34.49 57.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.385 -0.822 . . . . 0.2 109.395 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 5' ' ' HIS . . . . . 0.423 ' CD2' HG21 ' G' ' 10' ' ' ILE . 42.9 t60 -52.9 -21.69 4.61 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.456 -0.778 . . . . 0.14 110.583 -179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 6' ' ' LEU . . . . . 0.858 HD21 ' H4 ' ' G' ' 22' ' ' IPH . 26.5 mt -118.7 -28.87 5.53 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.089 -1.007 . . . . 0.05 109.899 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 7' ' ' CYS . . . . . 0.421 ' HB3' ' HA ' ' D' ' 4' ' ' GLN . 34.9 t -66.53 -45.46 79.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.173 -0.954 . . . . 0.04 109.758 -179.746 173.641 -172.364 132.111 102.921 2.022 105.015 81.663 -174.575 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . 0.401 ' HA3' ' OH ' ' D' ' 26' ' ' TYR . . . -60.92 -31.74 77.31 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 9' ' ' SER . . . . . . . . . . . . . 23.1 p -55.39 -24.32 29.25 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.987 -1.302 . . . . 0.01 110.039 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 10' ' ' HIS . . . . . 0.402 ' HA ' ' HG3' ' D' ' 13' ' ' GLU . 99.3 m-70 -103.85 -18.58 14.58 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.106 -0.996 . . . . 0.11 110.837 -178.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . 0.639 HD23 ' H5 ' ' C' ' 22' ' ' IPH . 57.1 mt -69.97 -34.64 73.64 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.383 -1.34 . . . . 0.01 107.383 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 12' ' ' VAL . . . . . 0.583 ' CG2' HG21 ' B' ' 12' ' ' VAL . 27.6 m -65.05 -36.7 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.906 -0.496 . . . . 0.0 110.031 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . 0.408 ' N ' HG23 ' D' ' 12' ' ' VAL . 26.3 mt-10 -54.77 -49.42 70.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.083 -1.01 . . . . 0.09 109.79 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 14' ' ' ALA . . . . . 0.488 ' O ' HG23 ' D' ' 18' ' ' VAL . . . -72.87 -28.68 62.65 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.302 -0.874 . . . . 0.01 109.413 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.401 ' HB2' ' HA ' ' D' ' 12' ' ' VAL . 9.3 mt -58.9 -64.6 0.88 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.362 -0.836 . . . . 0.0 110.173 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 16' ' ' TYR . . . . . 0.504 ' HB3' ' CE1' ' D' ' 24' ' ' PHE . 1.7 p90 -70.77 -12.69 61.7 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.131 -1.027 . . . . 0.0 110.93 -178.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 17' ' ' LEU . . . . . 0.598 HD11 ' H3 ' ' I' ' 22' ' ' IPH . 3.2 tt -73.66 -35.57 65.26 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 106.75 -1.574 . . . . 0.1 106.75 176.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . 0.488 HG23 ' O ' ' D' ' 14' ' ' ALA . 99.4 t -77.14 -35.57 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.429 -0.952 . . . . 0.14 108.429 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 19' ' ' CYS . . . . . 0.414 ' HB2' ' HA ' ' D' ' 16' ' ' TYR . 51.0 m -73.95 -22.84 59.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.416 -0.802 . . . . 0.06 109.456 179.611 -76.356 -89.899 173.834 103.866 2.017 104.06 77.085 -157.824 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.43 -115.73 5.19 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.553 -1.419 . . . . 0.13 109.553 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -83.7 -22.12 32.15 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.263 -1.14 . . . . 0.49 109.764 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 22' ' ' ARG . . . . . . . . . . . . . 31.9 mtm180 -59.03 177.53 0.15 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.083 -1.01 . . . . 0.29 109.564 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' B' ' 27' ' ' THR . . . -125.61 -176.29 14.48 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.54 -1.424 . . . . 0.01 109.54 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 24' ' ' PHE . . . . . 0.504 ' CE1' ' HB3' ' D' ' 16' ' ' TYR . 3.8 p90 -158.92 163.21 36.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.179 -1.189 . . . . 0.0 109.821 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 25' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -108.81 123.47 49.09 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.263 -0.898 . . . . 0.33 108.619 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 26' ' ' TYR . . . . . 0.401 ' OH ' ' HA3' ' D' ' 8' ' ' GLY . 53.4 t80 -109.84 115.94 30.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.36 -0.837 . . . . 0.0 109.719 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 27' ' ' THR . . . . . 0.431 ' HA ' ' HA3' ' B' ' 23' ' ' GLY . 36.8 p -125.47 98.55 34.7 Favored Pre-proline 0 N--CA 1.488 1.428 0 O-C-N 121.137 -0.977 . . . . 0.23 109.46 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 28' ' ' PRO . . . . . 0.538 ' HA ' HG21 ' C' ' 3' ' ' VAL . 36.7 Cg_endo -78.99 59.5 7.4 Favored 'Trans proline' 0 C--O 1.216 -0.591 0 C-N-CA 121.345 1.363 . . . . 0.04 109.91 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 29' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -160.02 75.64 0.61 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.41 -0.806 . . . . 0.41 109.531 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 30' ' ' THR . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.873 -1.06 . . . . 0.62 109.363 -179.99 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.539 -1.425 . . . . 0.28 109.539 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 2' ' ' ILE . . . . . 0.643 HD12 ' CG ' ' E' ' 19' ' ' TYR . 10.4 tt -130.6 -42.49 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -1.139 . . . . 0.05 109.216 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 3' ' ' VAL . . . . . 0.693 HG11 ' HG3' ' F' ' 4' ' ' GLN . 2.8 t -65.76 -62.11 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 121.324 -0.86 . . . . 0.01 109.327 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 4' ' ' GLU . . . . . 0.409 ' O ' HG23 ' E' ' 8' ' ' THR . 0.8 OUTLIER -58.9 -17.83 27.79 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.339 -0.85 . . . . 0.46 110.341 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 5' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -86.71 -35.51 19.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.995 -1.065 . . . . 0.24 110.515 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 6' ' ' CYS . . . . . . . . . . . . . 58.5 m -103.48 -23.89 13.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.943 -1.098 . . . . 0.0 110.957 -178.587 -54.825 -42.796 -97.243 104.528 2.023 104.035 129.417 -72.488 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 7' ' ' CYS . . . . . 0.421 ' HB2' HD11 ' F' ' 11' ' ' LEU . 47.6 t -76.19 -2.07 29.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.126 -0.983 . . . . 0.07 110.274 179.45 -174.647 81.733 132.048 104.804 2.024 102.944 -172.379 173.73 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 8' ' ' THR . . . . . 0.409 HG23 ' O ' ' E' ' 4' ' ' GLU . 16.1 p -86.51 -50.66 6.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.422 -1.424 . . . . 0.25 109.352 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 9' ' ' SER . . . . . 0.405 ' O ' ' HB ' ' E' ' 10' ' ' ILE . 16.2 m -155.07 37.1 0.39 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.917 . . . . 0.29 109.73 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 10' ' ' ILE . . . . . 0.628 HG23 ' C2 ' ' E' ' 22' ' ' IPH . 3.5 mp 64.07 139.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 121.993 0.901 . . . . 0.1 110.64 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 11' ' ' CYS . . . . . . . . . . . . . 66.8 m -95.03 174.07 7.26 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.976 -0.75 . . . . 0.05 108.976 179.409 -72.488 129.417 -97.243 104.035 2.023 104.528 -42.796 -54.825 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 19.4 m -83.36 165.11 19.55 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.26 -0.9 . . . . 0.27 109.166 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 13' ' ' LEU . . . . . . . . . . . . . 6.1 tt -59.1 -41.94 89.31 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.273 -0.892 . . . . 0.3 110.274 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 14' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -68.09 -39.22 82.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.071 -1.018 . . . . 0.52 110.178 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 15' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -58.01 -32.98 68.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.129 -0.982 . . . . 0.23 109.761 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 16' ' ' LEU . . . . . 0.418 ' HA ' HD23 ' E' ' 16' ' ' LEU . 85.5 mt -72.43 -29.23 63.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.938 . . . . 0.01 109.468 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -62.77 -31.43 72.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.309 -0.869 . . . . 0.26 109.949 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 48.4 m-20 -58.38 -28.78 65.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.203 -0.936 . . . . 0.42 109.48 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 19' ' ' TYR . . . . . 0.643 ' CG ' HD12 ' E' ' 2' ' ' ILE . 37.0 m-85 -96.83 13.89 27.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -0.931 . . . . 0.11 110.296 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 20' ' ' CYS . . . . . . . . . . . . . 5.0 t -83.68 156.76 22.48 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 120.875 -1.141 . . . . 0.05 109.522 -179.593 -157.805 77.064 173.72 104.164 2.018 103.744 -89.885 -76.218 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 C--N 1.301 -1.506 0 CA-C-O 117.934 -1.031 . . . . 0.43 109.369 -179.91 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' F' F ' 1' ' ' PHE . . . . . 0.545 ' O ' HG22 ' F' ' 2' ' ' VAL . 20.8 t80 . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.308 -0.627 . . . . 0.42 109.308 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 2' ' ' VAL . . . . . 0.545 HG22 ' O ' ' F' ' 1' ' ' PHE . 7.9 m 43.1 -158.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.748 -0.595 . . . . 0.13 111.38 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 3' ' ' ASN . . . . . 0.478 ' H ' HD11 ' A' ' 10' ' ' ILE . 2.2 t-20 -153.43 -172.0 4.09 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.25 -0.906 . . . . 0.27 109.572 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 4' ' ' GLN . . . . . 0.693 ' HG3' HG11 ' E' ' 3' ' ' VAL . 10.9 tt0 -53.03 -34.67 57.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.594 -0.691 . . . . 0.19 109.426 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 5' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -53.0 -21.68 4.74 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.438 -0.789 . . . . 0.14 110.533 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 6' ' ' LEU . . . . . 0.897 HD21 ' H4 ' ' A' ' 22' ' ' IPH . 26.5 mt -118.56 -28.96 5.55 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.098 -1.001 . . . . 0.06 109.939 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 7' ' ' CYS . . . . . 0.406 ' HB3' ' HA ' ' F' ' 4' ' ' GLN . 35.1 t -66.71 -45.75 77.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.325 -0.859 . . . . 0.04 109.654 -179.76 173.73 -172.379 132.048 102.944 2.024 104.804 81.733 -174.647 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.7 -31.09 74.12 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.594 -1.003 . . . . 0.0 110.594 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 9' ' ' SER . . . . . . . . . . . . . 22.3 p -56.22 -24.6 43.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.088 -1.242 . . . . 0.01 109.948 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 10' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -103.34 -18.56 14.8 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.184 -0.947 . . . . 0.11 110.893 -178.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . 0.651 HD23 ' H5 ' ' E' ' 22' ' ' IPH . 56.3 mt -69.89 -34.61 73.77 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.541 -1.281 . . . . 0.01 107.541 178.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 12' ' ' VAL . . . . . 0.595 HG21 HG21 ' H' ' 12' ' ' VAL . 28.6 m -64.95 -36.7 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.79 -0.569 . . . . 0.0 110.224 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 13' ' ' GLU . . . . . 0.412 ' N ' HG23 ' F' ' 12' ' ' VAL . 25.6 mt-10 -54.82 -49.39 71.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.065 -1.022 . . . . 0.09 109.752 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 14' ' ' ALA . . . . . 0.486 ' O ' HG23 ' F' ' 18' ' ' VAL . . . -73.09 -28.1 62.09 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.273 -0.892 . . . . 0.01 109.403 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 15' ' ' LEU . . . . . 0.423 ' HB2' ' HA ' ' F' ' 12' ' ' VAL . 9.2 mt -59.52 -64.23 1.02 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.342 -0.849 . . . . 0.01 110.33 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 16' ' ' TYR . . . . . 0.503 ' HB3' ' CE1' ' F' ' 24' ' ' PHE . 1.7 p90 -71.07 -11.96 61.25 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.851 -178.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 17' ' ' LEU . . . . . 0.549 HD11 ' H3 ' ' K' ' 22' ' ' IPH . 3.1 tt -74.17 -36.2 64.07 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 106.689 -1.597 . . . . 0.1 106.689 176.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 18' ' ' VAL . . . . . 0.486 HG23 ' O ' ' F' ' 14' ' ' ALA . 99.5 t -76.51 -35.44 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.486 -0.931 . . . . 0.14 108.486 178.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 19' ' ' CYS . . . . . 0.425 ' HB2' ' HA ' ' F' ' 16' ' ' TYR . 51.7 m -74.03 -22.87 59.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.36 -0.838 . . . . 0.06 109.636 179.607 -76.218 -89.885 173.72 103.744 2.018 104.164 77.064 -157.805 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.13 -115.52 5.19 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.583 -1.407 . . . . 0.13 109.583 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 21' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -83.89 -21.9 31.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -1.138 . . . . 0.48 109.712 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 22' ' ' ARG . . . . . 0.406 ' HB2' ' HB3' ' F' ' 19' ' ' CYS . 31.8 mtm180 -59.16 177.14 0.18 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.168 -0.958 . . . . 0.29 109.394 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 23' ' ' GLY . . . . . 0.416 ' HA3' ' HA ' ' H' ' 27' ' ' THR . . . -125.4 -176.42 14.53 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.308 -1.517 . . . . 0.01 109.308 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 24' ' ' PHE . . . . . 0.503 ' CE1' ' HB3' ' F' ' 16' ' ' TYR . 3.9 p90 -158.63 163.32 37.03 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.13 -1.217 . . . . 0.0 109.876 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 25' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -108.96 122.93 48.28 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.26 -0.9 . . . . 0.32 108.693 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 26' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -109.32 115.65 30.38 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.432 -0.792 . . . . 0.0 109.921 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 27' ' ' THR . . . . . 0.413 ' HA ' ' HA3' ' H' ' 23' ' ' GLY . 37.4 p -125.22 98.64 35.24 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.096 -1.002 . . . . 0.23 109.597 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 28' ' ' PRO . . . . . 0.528 ' HA ' HG21 ' E' ' 3' ' ' VAL . 36.7 Cg_endo -79.26 59.34 7.36 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 121.394 1.396 . . . . 0.04 109.752 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 29' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -159.84 75.31 0.62 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.283 -0.885 . . . . 0.4 109.458 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 30' ' ' THR . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.967 -1.016 . . . . 0.62 109.243 179.882 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' G' G ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.432 -1.467 . . . . 0.29 109.432 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' G' G ' 2' ' ' ILE . . . . . 0.634 HD12 ' CG ' ' G' ' 19' ' ' TYR . 10.3 tt -130.29 -42.46 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.251 -1.146 . . . . 0.05 109.201 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 3' ' ' VAL . . . . . 0.708 HG11 ' HG3' ' H' ' 4' ' ' GLN . 2.8 t -66.08 -61.73 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 121.321 -0.862 . . . . 0.01 109.283 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.08 -17.73 28.68 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.299 -0.876 . . . . 0.46 110.301 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 5' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -87.04 -35.16 18.91 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.844 -1.16 . . . . 0.25 110.417 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 6' ' ' CYS . . . . . . . . . . . . . 58.6 m -103.75 -23.49 13.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.992 -1.067 . . . . 0.0 110.969 -178.594 -54.875 -42.765 -97.092 104.532 2.022 104.065 129.374 -72.647 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 7' ' ' CYS . . . . . 0.412 ' HB2' HD11 ' H' ' 11' ' ' LEU . 48.4 t -76.58 -1.95 30.05 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.311 -0.956 . . . . 0.06 110.364 179.461 -174.504 81.704 131.985 105.072 2.022 102.829 -172.522 173.692 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 8' ' ' THR . . . . . . . . . . . . . 16.2 p -86.68 -50.55 6.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.452 -1.405 . . . . 0.24 109.34 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 9' ' ' SER . . . . . . . . . . . . . 16.4 m -154.91 37.12 0.4 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.92 . . . . 0.28 109.608 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 10' ' ' ILE . . . . . 0.635 HG23 ' C2 ' ' G' ' 22' ' ' IPH . 3.6 mp 63.99 139.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 122.005 0.907 . . . . 0.1 110.513 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 11' ' ' CYS . . . . . . . . . . . . . 66.2 m -95.6 174.24 7.09 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.966 -0.753 . . . . 0.05 108.966 179.419 -72.647 129.374 -97.092 104.065 2.022 104.532 -42.765 -54.875 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 12' ' ' SER . . . . . . . . . . . . . 19.3 m -83.54 165.2 19.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.239 -0.913 . . . . 0.28 109.111 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 13' ' ' LEU . . . . . . . . . . . . . 6.1 tt -59.13 -41.83 89.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.273 -0.892 . . . . 0.3 110.373 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 14' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -68.31 -38.86 82.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.088 -1.008 . . . . 0.53 110.176 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 15' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -58.31 -33.08 69.09 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.133 -0.979 . . . . 0.23 109.785 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 16' ' ' LEU . . . . . . . . . . . . . 85.1 mt -72.2 -29.5 64.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.15 -0.969 . . . . 0.01 109.506 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -62.67 -31.43 72.31 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.26 109.943 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 18' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -58.43 -28.58 65.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.236 -0.915 . . . . 0.4 109.42 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 19' ' ' TYR . . . . . 0.634 ' CG ' HD12 ' G' ' 2' ' ' ILE . 37.3 m-85 -96.82 13.39 28.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.151 -0.968 . . . . 0.11 110.348 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 20' ' ' CYS . . . . . . . . . . . . . 5.0 t -83.34 157.0 22.74 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.774 -1.203 . . . . 0.05 109.587 -179.554 -157.761 76.762 173.745 104.191 2.019 103.928 -89.746 -76.385 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 C--N 1.303 -1.429 0 CA-C-O 118.034 -0.984 . . . . 0.41 109.547 -179.903 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' H' H ' 1' ' ' PHE . . . . . 0.546 ' O ' HG22 ' H' ' 2' ' ' VAL . 21.1 t80 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.328 -0.619 . . . . 0.42 109.328 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 2' ' ' VAL . . . . . 0.546 HG22 ' O ' ' H' ' 1' ' ' PHE . 8.2 m 43.09 -159.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.68 -0.637 . . . . 0.12 111.44 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 3' ' ' ASN . . . . . 0.424 ' H ' HD11 ' K' ' 10' ' ' ILE . 2.2 t-20 -152.67 -172.4 4.23 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.306 -0.871 . . . . 0.26 109.772 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 4' ' ' GLN . . . . . 0.708 ' HG3' HG11 ' G' ' 3' ' ' VAL . 11.0 tt0 -52.55 -34.73 51.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.46 -0.775 . . . . 0.19 109.494 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 5' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -52.96 -21.52 4.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.341 -0.849 . . . . 0.14 110.497 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 6' ' ' LEU . . . . . 0.83 HD21 ' H4 ' ' K' ' 22' ' ' IPH . 27.2 mt -118.78 -28.55 5.57 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.052 -1.03 . . . . 0.05 109.971 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 7' ' ' CYS . . . . . 0.412 ' HB3' ' HA ' ' H' ' 4' ' ' GLN . 35.0 t -66.95 -45.63 77.19 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.243 -0.911 . . . . 0.04 109.66 -179.73 173.692 -172.522 131.985 102.829 2.022 105.072 81.704 -174.504 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.7 -31.46 75.43 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 9' ' ' SER . . . . . . . . . . . . . 21.5 p -55.82 -24.37 35.83 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.935 -1.332 . . . . 0.01 109.908 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 10' ' ' HIS . . . . . 0.405 ' HA ' ' HG3' ' H' ' 13' ' ' GLU . 99.1 m-70 -103.61 -18.98 14.52 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.085 -1.009 . . . . 0.11 110.889 -178.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . 0.651 HD23 ' H5 ' ' G' ' 22' ' ' IPH . 55.9 mt -69.6 -34.84 74.69 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.409 -1.33 . . . . 0.01 107.409 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 12' ' ' VAL . . . . . 0.595 HG21 HG21 ' F' ' 12' ' ' VAL . 27.8 m -64.77 -37.11 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.873 -0.517 . . . . 0.0 110.128 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 13' ' ' GLU . . . . . 0.407 ' N ' HG23 ' H' ' 12' ' ' VAL . 25.7 mt-10 -54.58 -49.3 70.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.084 -1.01 . . . . 0.09 109.875 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 14' ' ' ALA . . . . . 0.463 ' O ' HG23 ' H' ' 18' ' ' VAL . . . -73.0 -28.72 62.53 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.259 -0.9 . . . . 0.01 109.404 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 15' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' H' ' 12' ' ' VAL . 9.2 mt -58.8 -64.74 0.83 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.286 -0.884 . . . . 0.0 110.282 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 16' ' ' TYR . . . . . 0.499 ' HB3' ' CE1' ' H' ' 24' ' ' PHE . 1.7 p90 -70.61 -12.6 61.66 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.143 -1.023 . . . . 0.0 110.865 -178.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 17' ' ' LEU . . . . . 0.614 HD11 ' H3 ' ' A' ' 22' ' ' IPH . 3.3 tt -73.56 -36.0 65.55 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 106.745 -1.576 . . . . 0.1 106.745 176.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 18' ' ' VAL . . . . . 0.463 HG23 ' O ' ' H' ' 14' ' ' ALA . 99.5 t -76.85 -35.31 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 108.539 -0.912 . . . . 0.14 108.539 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 19' ' ' CYS . . . . . 0.416 ' HB2' ' HA ' ' H' ' 16' ' ' TYR . 50.9 m -74.02 -22.85 59.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.262 -0.899 . . . . 0.06 109.481 179.547 -76.385 -89.746 173.745 103.928 2.019 104.191 76.762 -157.761 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.31 -115.57 5.16 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.561 -1.416 . . . . 0.13 109.561 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -83.92 -21.67 31.8 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.309 -1.113 . . . . 0.48 109.807 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 22' ' ' ARG . . . . . 0.405 ' HB2' ' HB3' ' H' ' 19' ' ' CYS . 31.7 mtm180 -59.34 177.33 0.19 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.125 -0.984 . . . . 0.29 109.562 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 23' ' ' GLY . . . . . 0.426 ' HA2' ' HD2' ' F' ' 28' ' ' PRO . . . -125.54 -176.85 14.67 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.581 -1.408 . . . . 0.01 109.581 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 24' ' ' PHE . . . . . 0.499 ' CE1' ' HB3' ' H' ' 16' ' ' TYR . 3.9 p90 -158.43 163.39 37.25 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.2 -1.177 . . . . 0.0 109.786 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 25' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -109.14 123.06 48.6 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.246 -0.908 . . . . 0.34 108.702 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 26' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -109.55 115.66 30.33 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.366 -0.834 . . . . 0.0 109.834 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 27' ' ' THR . . . . . 0.416 ' HA ' ' HA3' ' F' ' 23' ' ' GLY . 36.4 p -125.3 98.39 35.5 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.159 -0.963 . . . . 0.24 109.442 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 28' ' ' PRO . . . . . 0.527 ' HA ' HG21 ' G' ' 3' ' ' VAL . 36.4 Cg_endo -79.05 59.88 7.56 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 121.333 1.355 . . . . 0.04 109.835 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 29' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -160.31 75.3 0.58 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.375 -0.828 . . . . 0.41 109.431 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 30' ' ' THR . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.949 -1.024 . . . . 0.62 109.369 179.88 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' I' I ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 N-CA-C 109.532 -1.427 . . . . 0.29 109.532 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' I' I ' 2' ' ' ILE . . . . . 0.656 HD12 ' CG ' ' I' ' 19' ' ' TYR . 10.4 tt -130.41 -42.33 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.192 -1.181 . . . . 0.05 109.278 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 3' ' ' VAL . . . . . 0.708 HG11 ' HG3' ' J' ' 4' ' ' GLN . 2.8 t -66.0 -61.96 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 121.396 -0.815 . . . . 0.01 109.243 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 4' ' ' GLU . . . . . 0.413 ' O ' HG23 ' I' ' 8' ' ' THR . 0.8 OUTLIER -58.73 -18.0 27.76 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.36 -0.838 . . . . 0.46 110.297 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 5' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -86.81 -35.47 19.09 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.874 -1.141 . . . . 0.24 110.498 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 6' ' ' CYS . . . . . . . . . . . . . 58.6 m -103.53 -23.49 13.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.896 -1.127 . . . . 0.01 110.959 -178.66 -54.866 -42.485 -97.48 104.518 2.023 104.012 129.157 -72.254 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 7' ' ' CYS . . . . . 0.418 ' HB2' HD11 ' J' ' 11' ' ' LEU . 48.2 t -76.65 -1.54 28.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.182 -0.949 . . . . 0.07 110.287 179.347 -174.534 81.725 132.409 104.818 2.022 102.974 -172.396 173.499 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 8' ' ' THR . . . . . 0.413 HG23 ' O ' ' I' ' 4' ' ' GLU . 16.0 p -86.98 -50.73 6.46 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.5 -1.375 . . . . 0.25 109.273 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 9' ' ' SER . . . . . . . . . . . . . 16.3 m -154.91 37.1 0.4 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.176 -0.952 . . . . 0.29 109.653 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 10' ' ' ILE . . . . . 0.643 HG23 ' C2 ' ' I' ' 22' ' ' IPH . 3.5 mp 64.13 139.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 122.001 0.905 . . . . 0.1 110.615 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 11' ' ' CYS . . . . . . . . . . . . . 67.6 m -95.27 174.21 7.16 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.986 -0.746 . . . . 0.05 108.986 179.459 -72.254 129.157 -97.48 104.012 2.023 104.518 -42.485 -54.866 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 12' ' ' SER . . . . . . . . . . . . . 18.6 m -83.47 164.65 19.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -0.923 . . . . 0.27 109.165 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 13' ' ' LEU . . . . . . . . . . . . . 6.0 tt -58.7 -41.57 86.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.377 -0.827 . . . . 0.3 110.337 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 14' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -68.68 -38.85 80.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.085 -1.01 . . . . 0.51 110.136 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 15' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -58.29 -33.26 69.25 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.243 -0.911 . . . . 0.22 109.745 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 16' ' ' LEU . . . . . . . . . . . . . 87.7 mt -72.05 -29.48 64.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.162 -0.961 . . . . 0.01 109.421 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -62.67 -31.14 71.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.333 -0.854 . . . . 0.27 109.914 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 18' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -58.72 -28.85 66.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.193 -0.942 . . . . 0.42 109.412 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 19' ' ' TYR . . . . . 0.656 ' CG ' HD12 ' I' ' 2' ' ' ILE . 37.0 m-85 -96.48 13.41 28.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 0.11 110.388 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 20' ' ' CYS . . . . . . . . . . . . . 4.9 t -83.3 156.6 22.99 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.769 -1.207 . . . . 0.05 109.622 -179.598 -157.649 77.17 173.7 104.136 2.018 103.758 -90.056 -76.247 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 t30 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.02 -0.99 . . . . 0.41 109.501 -179.977 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' J' J ' 1' ' ' PHE . . . . . 0.55 ' O ' HG22 ' J' ' 2' ' ' VAL . 20.8 t80 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.328 -0.619 . . . . 0.42 109.328 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 2' ' ' VAL . . . . . 0.55 HG22 ' O ' ' J' ' 1' ' ' PHE . 7.3 m 43.31 -159.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 121.764 -0.585 . . . . 0.13 111.422 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 3' ' ' ASN . . . . . 0.482 ' H ' HD11 ' E' ' 10' ' ' ILE . 2.2 t-20 -152.65 -172.09 4.13 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.363 -0.836 . . . . 0.27 109.791 -178.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 4' ' ' GLN . . . . . 0.708 ' HG3' HG11 ' I' ' 3' ' ' VAL . 10.9 tt0 -52.96 -34.41 55.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.504 -0.747 . . . . 0.2 109.422 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 5' ' ' HIS . . . . . 0.412 ' CD2' HG21 ' E' ' 10' ' ' ILE . 42.6 t60 -53.24 -21.27 5.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.408 -0.807 . . . . 0.14 110.516 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 6' ' ' LEU . . . . . 0.862 HD21 ' H4 ' ' E' ' 22' ' ' IPH . 26.7 mt -119.09 -29.05 5.35 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.225 -0.922 . . . . 0.06 109.92 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 7' ' ' CYS . . . . . 0.411 ' HB3' ' HA ' ' J' ' 4' ' ' GLN . 34.5 t -66.41 -45.53 79.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.274 -0.891 . . . . 0.04 109.728 -179.758 173.499 -172.396 132.409 102.974 2.022 104.818 81.725 -174.534 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 8' ' ' GLY . . . . . 0.401 ' HA3' ' OH ' ' J' ' 26' ' ' TYR . . . -60.89 -31.58 76.61 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 9' ' ' SER . . . . . . . . . . . . . 23.9 p -55.68 -24.27 33.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.946 -1.326 . . . . 0.01 110.016 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 10' ' ' HIS . . . . . 0.412 ' HA ' ' HG3' ' J' ' 13' ' ' GLU . 99.0 m-70 -103.89 -18.49 14.6 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.211 -0.931 . . . . 0.11 110.899 -178.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 11' ' ' LEU . . . . . 0.636 HD23 ' H5 ' ' I' ' 22' ' ' IPH . 56.7 mt -70.05 -34.3 73.05 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.419 -1.326 . . . . 0.01 107.419 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 12' ' ' VAL . . . . . 0.615 HG21 HG21 ' L' ' 12' ' ' VAL . 27.8 m -65.22 -37.05 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.783 -0.573 . . . . 0.0 110.05 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 13' ' ' GLU . . . . . 0.412 ' HG3' ' HA ' ' J' ' 10' ' ' HIS . 26.1 mt-10 -54.64 -48.77 71.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.04 -1.037 . . . . 0.1 109.836 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 14' ' ' ALA . . . . . 0.473 ' O ' HG23 ' J' ' 18' ' ' VAL . . . -73.63 -28.47 61.81 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.224 -0.922 . . . . 0.01 109.288 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 15' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' J' ' 12' ' ' VAL . 9.3 mt -58.94 -64.33 0.98 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.361 -0.837 . . . . 0.0 110.326 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 16' ' ' TYR . . . . . 0.498 ' HB3' ' CE1' ' J' ' 24' ' ' PHE . 1.8 p90 -71.04 -12.52 61.57 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.129 -1.029 . . . . 0.0 110.838 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 17' ' ' LEU . . . . . 0.608 HD11 ' H3 ' ' C' ' 22' ' ' IPH . 3.2 tt -73.89 -35.39 64.67 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 106.822 -1.547 . . . . 0.1 106.822 176.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 18' ' ' VAL . . . . . 0.473 HG23 ' O ' ' J' ' 14' ' ' ALA . 96.6 t -77.25 -35.66 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 108.279 -1.008 . . . . 0.13 108.279 178.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 19' ' ' CYS . . . . . 0.422 ' HB2' ' HA ' ' J' ' 16' ' ' TYR . 51.6 m -73.87 -22.7 59.64 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.372 -0.83 . . . . 0.06 109.509 179.614 -76.247 -90.056 173.7 103.758 2.018 104.136 77.17 -157.649 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.15 -115.44 5.15 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.593 -1.403 . . . . 0.13 109.593 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 21' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -84.0 -21.93 31.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.211 -1.17 . . . . 0.48 109.716 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 22' ' ' ARG . . . . . 0.413 ' HB2' ' HB3' ' J' ' 19' ' ' CYS . 31.5 mtm180 -59.07 177.46 0.16 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.071 -1.018 . . . . 0.29 109.526 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 23' ' ' GLY . . . . . 0.425 ' HA2' ' HD2' ' L' ' 28' ' ' PRO . . . -125.5 -176.16 14.44 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.459 -1.457 . . . . 0.01 109.459 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 24' ' ' PHE . . . . . 0.498 ' CE1' ' HB3' ' J' ' 16' ' ' TYR . 3.9 p90 -158.98 163.15 36.71 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.257 -1.143 . . . . 0.0 109.851 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 25' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -108.94 123.03 48.46 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.292 -0.88 . . . . 0.33 108.673 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 26' ' ' TYR . . . . . 0.401 ' OH ' ' HA3' ' J' ' 8' ' ' GLY . 52.8 t80 -109.47 115.54 30.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.444 -0.785 . . . . 0.0 109.866 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 27' ' ' THR . . . . . 0.434 ' HA ' ' HA3' ' L' ' 23' ' ' GLY . 36.2 p -125.24 98.55 35.35 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.157 -0.965 . . . . 0.24 109.459 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 28' ' ' PRO . . . . . 0.533 ' HA ' HG21 ' I' ' 3' ' ' VAL . 36.5 Cg_endo -79.05 59.68 7.49 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 121.282 1.321 . . . . 0.05 109.963 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 29' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -160.18 75.31 0.59 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.365 -0.834 . . . . 0.4 109.476 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 30' ' ' THR . . . . . . . . . . . . . 6.3 m . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 118.011 -0.995 . . . . 0.62 109.409 179.935 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' K' K ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.409 -1.476 . . . . 0.29 109.409 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' K' K ' 2' ' ' ILE . . . . . 0.654 HD12 ' CG ' ' K' ' 19' ' ' TYR . 10.3 tt -130.38 -42.47 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -1.195 . . . . 0.05 109.189 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 3' ' ' VAL . . . . . 0.713 HG11 ' HG3' ' L' ' 4' ' ' GLN . 2.8 t -65.96 -61.88 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.371 -0.831 . . . . 0.01 109.271 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 4' ' ' GLU . . . . . 0.403 ' O ' HG23 ' K' ' 8' ' ' THR . 0.8 OUTLIER -59.09 -17.53 27.01 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.224 -0.923 . . . . 0.46 110.333 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 5' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -87.09 -35.39 18.72 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.883 -1.135 . . . . 0.24 110.495 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 6' ' ' CYS . . . . . . . . . . . . . 58.4 m -103.68 -23.47 13.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.051 -1.03 . . . . 0.01 110.985 -178.653 -54.783 -42.815 -97.028 104.561 2.021 104.04 129.17 -72.535 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 7' ' ' CYS . . . . . 0.419 ' HB2' HD11 ' L' ' 11' ' ' LEU . 48.5 t -76.7 -1.57 28.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.102 -0.999 . . . . 0.06 110.289 179.359 -174.463 81.965 131.997 105.042 2.022 102.882 -172.541 173.841 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 8' ' ' THR . . . . . 0.403 HG23 ' O ' ' K' ' 4' ' ' GLU . 15.7 p -86.68 -50.57 6.69 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.435 -1.416 . . . . 0.25 109.216 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 9' ' ' SER . . . . . 0.402 ' O ' ' HB ' ' K' ' 10' ' ' ILE . 16.4 m -155.04 36.63 0.39 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.197 -0.94 . . . . 0.3 109.682 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 10' ' ' ILE . . . . . 0.651 HG23 ' C2 ' ' K' ' 22' ' ' IPH . 3.6 mp 64.57 138.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 122.069 0.937 . . . . 0.11 110.743 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 11' ' ' CYS . . . . . . . . . . . . . 66.7 m -94.86 174.46 7.09 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.001 -0.741 . . . . 0.05 109.001 179.407 -72.535 129.17 -97.028 104.04 2.021 104.561 -42.815 -54.783 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 12' ' ' SER . . . . . . . . . . . . . 19.0 m -83.52 165.08 19.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.191 -0.943 . . . . 0.27 109.102 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 13' ' ' LEU . . . . . . . . . . . . . 6.2 tt -58.99 -41.92 88.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.3 110.315 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 14' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -68.23 -39.45 82.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.005 -1.06 . . . . 0.51 110.077 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 15' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -57.78 -33.25 68.34 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.129 -0.982 . . . . 0.22 109.753 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 16' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' K' ' 16' ' ' LEU . 86.0 mt -72.1 -29.62 64.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.185 -0.947 . . . . 0.01 109.477 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -62.54 -31.28 72.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.26 109.9 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 18' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -58.71 -28.37 65.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.159 -0.963 . . . . 0.42 109.445 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 19' ' ' TYR . . . . . 0.654 ' CG ' HD12 ' K' ' 2' ' ' ILE . 36.7 m-85 -96.9 13.62 28.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.938 . . . . 0.11 110.296 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 20' ' ' CYS . . . . . . . . . . . . . 4.9 t -83.44 156.88 22.69 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.755 -1.216 . . . . 0.05 109.631 -179.553 -157.625 77.204 174.002 104.158 2.019 103.818 -90.005 -76.264 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 C--N 1.302 -1.467 0 CA-C-O 117.947 -1.025 . . . . 0.41 109.403 -179.881 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' L' L ' 1' ' ' PHE . . . . . 0.546 ' O ' HG22 ' L' ' 2' ' ' VAL . 21.2 t80 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.383 -0.599 . . . . 0.42 109.383 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 2' ' ' VAL . . . . . 0.546 HG22 ' O ' ' L' ' 1' ' ' PHE . 7.5 m 43.04 -158.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 CA-C-O 121.352 0.596 . . . . 0.12 111.408 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 3' ' ' ASN . . . . . 0.433 ' H ' HD11 ' C' ' 10' ' ' ILE . 2.2 t-20 -153.25 -172.19 4.16 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.248 -0.908 . . . . 0.26 109.664 -178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 4' ' ' GLN . . . . . 0.713 ' HG3' HG11 ' K' ' 3' ' ' VAL . 10.8 tt0 -52.79 -34.87 55.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.53 -0.731 . . . . 0.2 109.448 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 5' ' ' HIS . . . . . 0.414 ' CD2' HG21 ' C' ' 10' ' ' ILE . 43.2 t60 -52.84 -21.75 4.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.405 -0.81 . . . . 0.14 110.556 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 6' ' ' LEU . . . . . 0.841 HD21 ' H4 ' ' C' ' 22' ' ' IPH . 25.7 mt -118.51 -29.02 5.56 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.061 -1.024 . . . . 0.06 109.836 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 7' ' ' CYS . . . . . 0.417 ' HB3' ' HA ' ' L' ' 4' ' ' GLN . 35.4 t -66.54 -45.49 79.26 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.305 -0.872 . . . . 0.04 109.752 -179.701 173.841 -172.541 131.997 102.882 2.022 105.042 81.965 -174.463 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.03 -31.12 75.44 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 9' ' ' SER . . . . . . . . . . . . . 23.3 p -56.05 -24.41 39.46 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.07 -1.253 . . . . 0.01 109.965 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 10' ' ' HIS . . . . . 0.419 ' HA ' ' HG3' ' L' ' 13' ' ' GLU . 99.2 m-70 -103.51 -18.62 14.7 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.064 -1.022 . . . . 0.11 110.832 -178.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 11' ' ' LEU . . . . . 0.636 HD23 ' H5 ' ' K' ' 22' ' ' IPH . 55.7 mt -69.78 -34.17 73.38 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.414 -1.328 . . . . 0.01 107.414 178.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 12' ' ' VAL . . . . . 0.615 HG21 HG21 ' J' ' 12' ' ' VAL . 27.5 m -65.66 -36.62 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.715 -0.616 . . . . 0.0 110.134 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 13' ' ' GLU . . . . . 0.419 ' HG3' ' HA ' ' L' ' 10' ' ' HIS . 25.3 mt-10 -54.68 -49.69 70.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.144 -0.972 . . . . 0.09 109.774 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 14' ' ' ALA . . . . . 0.477 ' O ' HG23 ' L' ' 18' ' ' VAL . . . -72.72 -28.87 62.92 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.32 -0.863 . . . . 0.01 109.235 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 15' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' L' ' 12' ' ' VAL . 9.1 mt -58.87 -64.17 1.03 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.361 -0.837 . . . . 0.0 110.257 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 16' ' ' TYR . . . . . 0.501 ' HB3' ' CE1' ' L' ' 24' ' ' PHE . 1.7 p90 -71.18 -12.12 61.31 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.911 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 17' ' ' LEU . . . . . 0.584 HD11 ' H3 ' ' E' ' 22' ' ' IPH . 3.2 tt -74.04 -35.83 64.35 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 106.763 -1.569 . . . . 0.1 106.763 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 18' ' ' VAL . . . . . 0.477 HG23 ' O ' ' L' ' 14' ' ' ALA . 98.3 t -76.85 -35.31 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.391 -0.966 . . . . 0.13 108.391 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 19' ' ' CYS . . . . . 0.421 ' HB2' ' HA ' ' L' ' 16' ' ' TYR . 51.5 m -74.32 -22.39 59.28 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.385 -0.822 . . . . 0.06 109.556 179.636 -76.264 -90.005 174.002 103.818 2.019 104.158 77.204 -157.625 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.84 -115.37 5.21 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.636 -1.386 . . . . 0.13 109.636 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -84.0 -22.13 31.45 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.244 -1.151 . . . . 0.49 109.744 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 22' ' ' ARG . . . . . 0.405 ' HB2' ' HB3' ' L' ' 19' ' ' CYS . 32.2 mtm180 -59.07 177.58 0.16 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.3 109.54 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 23' ' ' GLY . . . . . 0.434 ' HA3' ' HA ' ' J' ' 27' ' ' THR . . . -125.75 -176.52 14.55 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.464 -1.455 . . . . 0.01 109.464 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 24' ' ' PHE . . . . . 0.501 ' CE1' ' HB3' ' L' ' 16' ' ' TYR . 3.7 p90 -158.67 163.6 36.72 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.081 -1.247 . . . . 0.0 109.859 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 25' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -109.29 122.67 47.85 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.278 -0.889 . . . . 0.33 108.733 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 26' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -109.08 115.73 30.6 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.414 -0.804 . . . . 0.0 109.84 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 27' ' ' THR . . . . . 0.423 ' HA ' ' HA3' ' J' ' 23' ' ' GLY . 36.4 p -125.3 98.57 35.16 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.088 -1.007 . . . . 0.23 109.45 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 28' ' ' PRO . . . . . 0.524 ' HA ' HG21 ' K' ' 3' ' ' VAL . 36.6 Cg_endo -79.0 59.54 7.42 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 121.355 1.37 . . . . 0.04 109.865 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 29' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -160.06 75.48 0.6 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.389 -0.819 . . . . 0.4 109.502 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 30' ' ' THR . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.903 -1.046 . . . . 0.62 109.469 179.899 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' IPH . . . . . 0.897 ' H4 ' HD21 ' F' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' IPH . . . . . 0.841 ' H4 ' HD21 ' L' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 22' ' ' IPH . . . . . 0.862 ' H4 ' HD21 ' J' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 22' ' ' IPH . . . . . 0.858 ' H4 ' HD21 ' D' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 22' ' ' IPH . . . . . 0.849 ' H4 ' HD21 ' B' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 22' ' ' IPH . . . . . 0.83 ' H4 ' HD21 ' H' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_